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ABSTRACT OF THE DISSERTATION 
REGULATORY MECHANISMS OF LEISHMANIA AQUAGLYCEROPORIN AQP1 
by 
Mansi Sharma 
Florida International University, 2015 
Miami, Florida 
Professor Rita Mukhopadhyay, Major Professor 
Pentavalent antimonials [Sb(V)] are the primary drug of choice against all forms 
of leishmaniasis.  Emergence of antimony unresponsiveness is a major issue. There is a 
dire need of understanding antimony resistance mechanisms in Leishmania. One 
important mechanism is the down regulation of the trivalent antimony [Sb(III)] (the 
active form of Sb(V)) uptake system.  To date, Leishmania aquaglyceroporin AQP1 is the 
only reported facilitator of Sb(III).  Leishmania do not have promoters.  They primarily 
regulate their genes at post-transcriptional and/or post-translational levels.  We reported 
that mitogen activated protein kinase 2 (MPK2) positively regulated AQP1 stability 
through the phosphorylation of the threonine 197 (T197) residue of AQP1.  The goal of 
this study was to elucidate the regulatory mechanism(s) of AQP1 in Leishmania in order 
to advance our understanding about the physiological role(s) of AQP1 in Leishmania 
biology.  When Leishmania promastigotes were treated with the proteasome inhibitor 
MG132, SbIII accumulation was increased due to upregulation of AQP1.  Alteration of 
lysine 12 of AQP1 to either alanine or arginine improved protein stability.  Cells co-
expressing a dominant-negative MPK2 mutant exhibited severely reduced AQP1 
expression, which was reversed upon addition of MG132.  Interestingly, the dominant-
   ix 
negative MPK2 mutant could not destabilize either AQP1K12A /AQP1K12R.  Stabilization 
of AQP1 by MPK2 led to its relocalization from the flagellum to the entire surface of the 
parasite. Both altered AQP1K12A and AQP1K12R were restricted to the flagellum only. The 
data demonstrated that lysine12 was targeted for AQP1 proteasomal degradation playing 
an integral role in subcellular localization of AQP1 as well as its interaction with MPK2.   
This study also demonstrated that the stability of AQP1 mRNA in different 
Leishmania species was regulated by their respective 3’-untranslated regions.  Cutaneous 
leishmaniasis causing species accumulated more antimonite and therefore, exhibited 
higher sensitivity to antimonials than species responsible for visceral leishmaniasis.  This 
species-specific differential sensitivity to antimonite was found to be directly 
proportional to the expression levels of AQP1 mRNA. The differential regulation of 
AQP1 mRNA explained the distinct antimonial sensitivity of each species.  This study 
will help us to identify new drugs for treatment in the future and also lead to a novel 
understanding of parasite biology aspects such as integral membrane protein trafficking 
and regulation. 
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INTRODUCTION 
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1. Introduction to leishmaniasis 
Leishmaniasis is a range of different diseases caused by an obligate intracellular 
protozoan parasite of the genus Leishmania (Order Kinetoplastida).  It is classified as one 
of the most dreadful and neglected tropical diseases.  Of the 30 species, 21 are known to 
infect mammals, including human beings. Leishmaniasis is one of the most commonly 
acquired cutaneous travel diseases, along with larva migrans, bacterial ulcers, and 
ecthyma (Von Stebut 2014).  The disease is endemic in 88 countries, predominantly in 
the tropics, subtropics, and southern Europe.  According to the World Health 
Organization (WHO), 90% of the disease is concentrated  in six “Old World” countries 
(Afghanistan, Algeria, Saudi Arabia, Iran, Sudan, and Syria) and in two “New World” 
countries (Brazil and Peru) (Figure 1) (Von Stebut, 2014).  
 
Two million new cases are reported each year, adding up to almost 12 million people 
currently infected worldwide.  Of great concern is a WHO report states that 350 million 
people are at a risk of infection (Reithinger et al., 2007).  Leishmaniasis can be expressed 
in three different clinical forms: cutaneous (CL), mucocutaneous (MCL) and visceral 
leishmaniasis (VL).  
   3 
1.1 Cutaneous leishmaniasis (CL) 
 Cutaneous leishmaniasis (CL), also known as oriental sore, tropical sore, or 
chiclero ulcer, is the most common form of leishmaniasis in humans (Choi and Lerner, 
2001).  It is considered to be the least severe clinical form of the disease and causes skin 
sores or lesions usually at the site of the sandfly bite or in close proximity to it.  The 
growth of intracellular amastigotes leads to localized lesions because of the release of 
cytokines at the inoculation site.  In immunocompetent individuals, lesions heal after 6-
18 months (Lesho et al., 2004).  Cutaneous leishmaniasis is endemic in more than 70 
countries; 90% of these cases occur in Afghanistan, Algeria, Brazil, Pakistan, Peru, Saudi 
Arabia, and Syria (Reithinger et al., 2007) (Figure 1)  The disease has an estimated 
annual incidence rate of 1.5- 2 million cases.   In the Old World, L. major and L. tropica 
cause CL, whereas in the New World, L. mexicana and members of Leishmania 
(Viannia) braziliensis, Leishmania (Viannia) guyanensis, and Leishmania (Viannia) 
panamensis are the most common causes of the disease (Lesho et al., 2004).  There are 
seven clinical features that correlate well closely with the diagnosis of Old World 
Cutaneous leishmaniasis: (i) Exposed site location, (ii) Pairing or clustering of lesions, 
(iii) Orientation of the skin sore along the skin crease, (iv) Volcano-like ulcer, (v) 
Inflammatory satellite papules, (vi) Proximal, sporotrichoid, subcutaneous nodules, and 
(vii) Subcutaneous induration extending underneath the skin lesion (Lesho et al., 2004). 
  Cutaneous leishmaniasis has four distinct forms as localized, disseminated, 
recidivans, and diffused leishmaniasis (Lesho et al., 2004).  Localized Cutaneous 
leishmaniasis, also known as Baghdad boil, is usually the result of the development of 
inflammatory skin sores, leaving scars during the healing process.   Usually, localized 
   4 
Cutaneous leishmaniasis is asymptomatic at first and later presents non-specific 
erythematous papules that can be easily confused with an insect bite.  As time progresses, 
these erythematous papules expand slowly.  The lesions appear to be nodular, plaque like, 
or ulcerative (Herwaldt, 1999) (Figure 2A and B).  The speed of recovery from localized 
CL depends on the type of infective species.   
   
  An unusual variant of Cutaneous leishmaniasis is Leishmaniasis recidivans, 
caused by L. tropica, and often referred to as “Chronic Lupoid Leishmaniasis” because of 
its resemblance to lupus vulgaris.  This is a chronic, non-healing or relapsing lesion that 
appears on or at the edge of the sores produced by previous cutaneous lesions.  The onset 
of disease is usually within two years of the original disease, but much later onset has 
been reported following trauma or topical steroid use (Lesho et al., 2004).    
  Another rare form of the disease is diffused Cutaneous leishmaniasis, which is 
caused mainly by L. aethiopica in Africa and L. mexicana amazonensis in the New 
World.  In these cases, the lesions are spread from one site to another.  The infection is 
characterized by abundant parasitization and absence of an inflammatory response.   
   5 
1.2 Mucocutaneous leishmaniasis (MCL) 
Mucocutaneous leishmaniasis (MCL) is one of the atypical forms of American 
Tegumentary leishmaniasis (ATL).  This form of disease is endemic throughout areas of 
Latin America (Figure 1).  Throughout the world, 12 million cases of MCL have been 
reported with an increase of 1.5 million new cases each year (Amato et al., 2008).  L. 
panamensis, L. guyanensis, L. amazonensis are responsible for the clinical form of the 
disease, although it is most commonly caused by L. braziliensis.  The infection caused by 
L. braziliensis leads to one of the most life-threatening and disfiguring forms of the 
disease, which is known as Espundia (Figure 3).  Onset of MCL occurs months or years  
after the primary cutaneous lesions appear.  In this clinical form of leishmaniasis, 
parasites metastasize to mucous tissues through lymphatic or hematogenous 
dissemination.  The MCL symptoms begin with nasal inflammation and stuffiness 
leading to later ulceration in the host’s nasal mucosa. These hosts present concomitant 
lesions in the palate, larynx, and trachea.  Mucocutaneous leishmaniasis is very difficult 
to treat, and if left untreated, potentially fatal secondary bacterial infections occur.  Long-
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term consequences may also include severe facial disfiguration and respiratory 
disturbances that do not self-heal (Amato et al., 2008).  
1.3 Visceral leishmaniasis 
  Visceral leishmaniasis (VL), most commonly known as Kala-azar is the most 
severe clinical form of the disease.  According to a report by (Alvar et al., 2008) the 
incidence of VL is calculated as high as 0.2-0.4 million per year, with more than 90% in 
India, Bangladesh, Sudan, Ethiopia, and Brazil; mortality is estimated at 10-20%, 
especially in poor regions.  Visceral leishmaniasis is hypoendemic in Mediterranean 
countries (Savoia, 2015) (Figure 1), comprising 5%-6% of the reported global cases. 
Usually, infections remain asymptomatic, but conditions such as malnutrition and 
immune suppression related to HIV, may lead to the clinical symptoms associated with 
VL.  Leishmania donovani and Leishmania infantum are the two major species 
responsible for VL.  Leishmania replicates in macrophages and mainly affects organs 
such as the liver, spleen and bone marrow (Alvar et al., 2008). Symptoms may take 
months or even years to develop (Monge-Maillo et al., 2014).  Fatal if untreated, VL is 
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associated with fever, weight loss, hepatosplenomegaly (Figure  4), anemia, leukopenia 
and thrombocytopenia (Monge-Maillo et al., 2014).  Primary lesions in VL are rarely 
evident; they consist of small erythematous papules, which are known as 
“leishmaniomas”.  During the active stages of VL, the skin blackens, hence it is known as 
“Kala-azar” or “black fever” (Choi and Lerner, 2001).  Patients suffering from VL have 
increased IgG and IgM levels, which leads to a depression in cell-mediated immunity.  
Depress immunity in turn then leads to patients becoming more susceptible to a variety of 
secondary opportunistic infections (Haldar et al., 1983).  Immunodeficient individuals are 
unable to have successful treatment results leading to relapse later on (Berman et al., 
1985). 
Post kala- azar dermal leishmaniasis (PKDL) is caused by L. donovani and is 
endemic in East Africa and India.  Twenty percent of patients in India recovering from 
visceral leishmaniasis contract PKDL (Bittencourt et al., 2002).  Usually, small hypo-
pigmented macules occur and then enlarge to form irregular patches.  Lesions appear, and 
erythematous macules develop, particularly in the hypo-pigmented areas on the face.  
These macules are replaced by soft, painless, non-ulcerative, yellowish-pink nodules, 
which commonly appear on the face, earlobes, trunk, and genitalia.  However, these non-
ulcerative nodules are less frequent in areas such as the hands and feet.  Patients suffering 
from PKDL require longer courses of systemic medication (Choi and Lerner, 2001). 
1.4 Life cycle of Leishmania  
The life cycle of Leishmania includes two morphologically distinct forms, the 
promastigote and the amastigote stages.  Promastigotes (Figure 5A) are slender spindle-
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shaped bodies with elongated anterior flagella that reside within the gut of sandflies.  In 
contrast, amastigotes (Figure 5B) are small, oval-shaped, non-flagellated structures that 
reside inside the phagolysosomes of the host macrophages (Kamhawi, 2006).   
Amastigotes multiply by binary fission and finally burst open out of the infected cell.  
They are then taken up by non-infected macrophages or other mononuclear phagocytic 
cells, thus propagating the disease (Figure 6). 
The pathogenicity cycle begins with an infected sandfly biting a vertebrate host.    
From the sandfly proboscis, the infected promastigote then gets injected into the skin of 
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the healthy host.  Once the injected promastigotes are phagocytized by the host 
macrophages, they are transformed into amastigotes, which is known as the parasitic 
tissue stage (Figure 6).  The rapid morphological transformation and parasitic 
development takes place because of differences in conditions such as pH and temperature 
inside the gut of the sandfly and the vertebrate host.  Initially, amastigotes transform into 
small, sluggish, motile, dividing forms with short anterior flagellum known as procyclic 
promastigotes, which are located within the peritrophic matrix (Kamhawi, 2006) and 
observed in early bloodmeal.  Procyclic form of promastigotes is relatively resistant to 
digestive enzymes (Kamhawi, 2006).  After 48-72 hours, procyclics differentiate into 
nectomonad promastigotes, which are large, slender in shape, and non- dividing but 
highly motile.  After they escape from the peritrophic matrix, the nectomonads attach 
themselves to the epithelial cell lining of the midgut and migrate towards the anterior 
thoracic midgut.  The nectomonads then differentiate into leptomonads.  Division of 
leptomonads results into a severe infection at the anterior midgut.  Leptomonads then 
differentiate into non-motile haptomonads promastigotes with short flagella and highly 
motile metacyclic promastigotes with long anterior flagellum (Kamhawi, 2006).  The 
non- dividing metacyclics usually accumulate at the stomodeal valve, ensuring the 
availability of the parasites for the transmission (Figure 7).  To prevent or reduce the 
influx of blood into the midgut, leptomonads form a parasite secretory gel (PSG) plug.  
When the PSG plug and non-functional stomodeal valve are combined, a mechanism is 
created that  enables the sandfly to expel or regurgitate  the metacyclics located in front 
of or within the PSG plug onto the skin of the vertebrate host, restarting the life cycle 
(Ramalho-Ortigão et al., 2005).  
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1.5 History of leishmaniasis 
  Leishmaniasis is an ancient disease tracing its history back to the Pre-Cambrian 
Era.  Archaeological findings suggest the presence of chronic ulcers in mummified 
remains (Tuon et al., 2008).  Any evidence confirming the presence of VL is absent from 
ancient records.  Alexander Russel produced the first modern illustrations of the disease 
in 1756.  In 1903, L.H. Donovan and W.B. Leishman clinically demonstrated the 
causative parasite in the splenic tissue, laying the cornerstone for widespread research of 
the disease.  Momen and Cupolillo (2000) suggested that following the extinction of 
dinosaurs, the genus of Leishmania first appeared during the Paleogene of Paleocene. 
During the Paleocene period, Leishmania was divided into Sauro Leishmania, which 
affects reptiles, and the current Leishmania, which affects mammals.  Studies offer vague 
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yet logical theories about the origin of Leishmania (Tuon et al., 2008).  Leishmania 
belongs to the phylum Kinetoplastida, which unfortunately has no current fossil record.  
Dooijes et al. (2000) suggested that the kinetoplastids are probably related to the 
euglenids, which according to Roger and Hug (2006), are related to the eukaryote super 
group Excavata, and hence, must have appeared during Ordovcian.   Croan et al. (1997) 
reported that approximately 21 species of the genus Leishmania caused leishmaniasis.  
According to Hide et al. (2007), the species were divided into subgenera: Leishmania of 
the Old World and Viannia in the New World.  The understanding of New World 
Leishmania comes from the appearance of mucosa lesions, which were common for pre-
Colombian inhabitants.  The historical dispersal of the Leishmania parasite is based on 
the simultaneous origin of winged insects, which later created the lineage of the sandflies.  
The disintegration of the Pangea forming the Gondwana led to the division of two genera 
– Phlebotomus and Lutzomiya.  Lutzomiya, according to Killick-Kendrick (1990), is 
responsible for the transmission of leishmaniasis in the New World.  The vector-parasite-
host transmission of Leishmania is the most plausible theory.  During the Jurassic times, 
Gondwana was separated from Pangea, disseminating the vector (sandflies) and the hosts 
(mammals) throughout the world, with the exception of the Neoartic region, where it 
arrived during the Paleocene Era.  It is believed that a primitive rodent brought 
Leishmania to the New World during the Neocene Era (Noyes, 1998).  Noyes et al. 
(1997) are of the view that the parasite spread from North America to Asia, Europe and 
Africa via this route.  Another theory suggests that migration from the Neotropics to the 
Neoartic and further into the Paleoartic might have been a possible route for the parasite 
(Yurchenko et al., 2006; Lukes et al., 2007) 
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1.6 Treatment  
Since the 1940s, Pentostam and Glucantime - the two organic pentavalent 
antimonial compounds have been the basis for all forms of treatment of leishmaniasis.  
However, pentavalent antimonial resistance to all clinical forms of leishmaniasis 
represents a challenge to the community of scientists and clinicians committed to 
effective treatment of the disease.  In North-East India, more than 50% of patients 
suffering from VL have become resistant to Pentostam (Sundar and Rai, 2002), and there 
are several reports of trivalent antimony resistance (Ouellette et al., 1998). Amphotericin 
B and pentamidine are the second line of anti-leishmanial drugs (Figure 8).  Alkyl 
lysophospholipids (ALP), such as miltefosine (Figure 8) and edelfosine, used as  
anticancer treatment previously, have shown significant promise by counteracting the 
proliferative activity against Leishmania (Urbina, 1997).  Miltefosine was the first oral 
   13
drug given in India to treat cases of VL and antimony-resistance (Sundar and Rai, 2002).  
Other drugs, such as allopurinol, atovaquone, fluconazole, paromomycin, and 
sitamaquine (Figure 8), are currently in various stages of clinical trials (Sundar et al., 
2011).  
  Both clinical and laboratory-induced drug resistance have been observed with 
these drugs. Understanding the drug resistance mechanism will help to identify drug  
targets and design tools to aid recognition of resistance early in the treatment process, 
enabling clinicians to begin alternate or combination therapies (Mandal et al., 2014).  
Leishmania employs several mechanisms to confer drug resistance (Borst and Ouellette, 
1995).  These include (i) downregulation of the uptake system(s) for the drug, (ii) 
intracellular sequestration, (iii) drug inactivation or modification, (iv) modification of the 
drug target to prevent binding of the drug or overproduction of the target so that drug 
concentration becomes limiting, (v) more efficient repair of drug damage, and (vi) 
bypassing a blocked target (Mandal et al., 2014).  My next section will concentrate on 
antimonial resistance in the next sections as my graduate research involves the regulation 
of the only antimonial uptake system in Leishmania, which is also involved in drug 
resistance. 
1.7 Antimonial mechanism of action and resistance 
Pentavalent antimonials have been used as the first line of treatment against all 
forms of leishmaniasis.  The recommended dosage of pentavalent antimony [Sb(V)]  is 
20 mg/ kg for 20- 28 days.  Longer courses of medication can induce toxicity in patients 
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and present symptoms such as fatigue, body aches, electrocardiographic abnormalities, 
raised amino-transferase levels, and chemical pancreatitis (Herwaldt, 1999).   
1.7.1 Mechanism of action: For the past six decades, cellular and molecular mechanisms 
have not been clearly understood for pentavalent antimonials. In vivo metabolic 
conversion of pentavalent [Sb(V)] to trivalent [Sb(III)], the active form of the drug was 
suggested half a century ago (Goodwin, 1995).  When hamsters were infected with 
Leishmania garnhami and then treated with Glucantime [Sb(V)], it was observed that 
serum concentrations of Sb(III) and Sb(V) were similar; it was assumed that reduction of 
Sb(V) to Sb(III) could reduce the size and improve leishmanial ulcer healing (Lugo de 
Yarbuh, 1994).   Several studies indicated that Sb(III) is more toxic than Sb(V) to either 
of the parasite stages.  It was found that Sb(III) had a higher level of susceptibility as 
opposed to Sb(V) when amastigotes of L. infantum were grown under laboratory 
conditions (Sereno and Lemesre, 1997).  Under the laboratory environment, amastigotes 
of L. infantum were also poorly responsive to meglumine [Sb(V)], as compared to 
amastigotes grown in human macrophages (Sereno et al., 1998).  Sb(V) unresponsiveness  
suggested a putative reductase, which catalyzes the conversion of Sb(V) to Sb(III) within 
the macrophages. However, does Leishmania have a Sb(V) reductase? Given the fact that 
arsenical resistance Leishmania strains are mostly cross-resistant to antimonials, it was 
safely deduced that Sb(V) may be reduced by Leishmanial As(V) reductase as a result of 
arsenic and antimony being related metalloids.  Zhou et al. (2004) used Saccharomyces 
cerevisiae arsenate reductase (ScAcr2p) sequence to identify and clone the L. major 
homologue, LmACR2.  In terms of arsenate sensitivity, LmACR2, when overexpressed 
in Escherichia coli or S. cerevisiae arsenate reductase disrupted strains, complemented 
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the Sb(V)/As(V) sensitivity.  Pentostam sensitivity was found to be increased in 
intracellular amastigotes when L. infantum was transfected with LmACR2.  Furthermore, 
when LmACR2 was purified, it was shown to reduce both As(V) and Sb(V) in vitro.  As a 
result, it was theorized that LmACR2 was essential in reducing the pentavalent antimony 
in Pentostam to the Leishmania active trivalent form of the drug (Zhou et al., 2004).   
Thiol dependent reductase (TDR1), a parasite-specific enzyme, was first 
identified and characterized by Denton et al. (2004) from L. major.  Thiol dependent 
reductase 1 catalyzes the reduction of pentavalent form of antimonials to the trivalent 
form using glutathione as a reductant (Denton et al., 2004).  The enzyme is a tetramer 
protein, containing two domain monomers, each of which is part of the omega class of 
glutathione S- transferases (GSTs).  The enzyme is highly abundant in the mammalian 
stage of the parasite, which may explain the increased effectiveness of the drug during 
this stage (Sundar et al., 2007).  Studies conducted by Berman et al. (1985) showed that 
L. mexicana promastigotes and amastigotes viability was impaired when exposed to 500 
μg/ml of sodium stibogluconate.  Such exposure resulted in a decrease in the 
incorporation of radiolabel [(14C leucine), (3H uridine), (3H thymidine)] into purine 
nucleoside triphosphate and an increase in the incorporation of radiolabel into purine 
nucleoside monophosphate, and diphosphate.  Further studies suggested that antimonials 
possibly act by downregulating processes such as glycolysis and fatty acid β- oxidation.  
  It was reported that one of the probable mechanisms of action may be the 
antimonials’ ability to inhibit Leishmania topoisomerase I.  Chakraborty et al. (1988) 
confirmed that L. donovani topoisomerase I is able to catalyze relaxation of supercoiled 
plasmid pBR322 aided by the inhibition of sodium stibogluconate.  Different dosage 
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inhibition of sodium stibogluconate suggested that antimonials do not interact with DNA 
as previously thought but with Leishmania topoisomerase I.  Another possible 
mechanism may be the involvement of antimonials in the mitochondrial depolarization 
and associated thiol loss.  As a result of the mitochondrial depolarization and the thiol 
loss, there is less production of ATP and an increase of oxidative bursts within the 
phagolysosomes of macrophages (Mehta and Shaha, 2006).  The oxidative burst 
occurring within the macrophages takes place via the phosphorylation of 
phosphoinositide 3- kinase (PI3K), protein kinase C (PKC) Ras and extracellular-signal 
regulated kinase (ERK). Inhibition of these proteins emphasizes the importance of 
oxidative bursts within phagolysosomes of infected macrophages (Mookerjee Basu et al., 
2006). 
  Programmed cell death (PCD) by antimony use is one of the mechanisms 
responsible for killing the parasites involving DNA fragmentation and externalization of 
phosphotidylserine on the outer surface of the membrane (Sereno et al., 2001).  In vitro 
studies indicate that trypanothione reductase (TR) and glutathione synthetase are 
inhibited by Sb(III).  Rapid efflux of trypanothione (TSH) and GSH occurs as soon as 
promastigotes and amastigotes are exposed to Sb(III), which sometimes compromises the 
redox potential of the cell.  Studies have shown that Sb(III) is active against both stages 
of the parasite, whereas Sb(V) is active only in intracellular amastigotes.  Shaked Mishan 
et al. (2001) showed that Sb(V) is reduced to Sb(III) in axenic amastigotes.                                  
1.7.2 Mechanism of resistance:  The mechanism of antimonial resistance is an important 
area of research in Leishmania.  Several studies have indicated that antimonial resistance 
is multifactorial.  Parasites use one or more mechanisms to become unresponsive to 
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antimonials.  Antimonial drugs must enter the host cell and act against the intracellular 
parasite.  However, the antimonials [Sb(V)]  route of entry of the parasite into the 
macrophage is not yet well understood, but as stated in an earlier section,  Sb(V) is 
reduced to Sb(III) to become anti-leishmanial.  Accumulation of Sb(III) has been 
observed in both  stages of Leishmania, but variation in Sb(III) and Sb(V) accumulation 
levels suggests different routes of entry for the two forms of antimony.  In an earlier 
section (1.7.1), we described how LmACR2 confers Pentostam hypersenitivity and 
displays arsenate and antimonate reductase activities.  Leishmania major arsenate 
reductase (LmACR2) dephosphorylates phosphotyrosine residues in leishmanial proteins 
(Zhou et al., 2004).  Thiol dependent reductase 1 is a reductase whose activity was  found 
to be 10 times higher in L. major amastigotes as compared to promastigotes (Fakhri 
Jeddi, 2011), but the enzymatic function in antimonial resistance has yet to be determined 
in clinical isolates (Mandal et al., 2015).  The most common factors for antimonial 
resistance are: (i) MRPA ; (ii) thiols ; (iii) an unknown efflux system and (iv) 
aquaglyceroporin (AQP1) (Mandal et al., 2015). 
The ATP- binding cassette (ABC) transporters play an essential role in a variety 
of physiological processes.  Their presence extends from prokaryotes to humans, and they 
are evolutionarily highly conserved (Manzano et al., 2013).  The ABC transporters are 
involved in the transport of different compounds across biological membranes, including 
anti-leishmanicidal agents, such as antimonials, miltefosine, pentamidine and 
sitamaquine, using energy through ATP hydrolysis (Manzano et al., 2013).  They have 
also been identified in Leishmania, in which they have been amplified extra-
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chromosomally in many species in response to a variety of drugs under controlled 
environments (Ouellette et al., 1998).  There are two types of ABC transporters 
responsible for multi- drug resistance in mammalian cells:  P-glycoprotein (P-gp) and 
multi-drug resistance- related protein (MRP).  The MRP1 family is known to be involved 
in thiol- associated efflux and metal resistance (Haimeur et al., 2000).  Analyses of the 
Leishmania genome lead to the identification of eight putative protein homologues 
belonging to the MRP1 family, which are functionally distinct from mammalian MRP.  
In Leishmania, one of the ABC transporters is PGPA (aka MRPA), which belongs to the 
ABCC subfamily (ABCC3) and plays a significant role in metal resistance, extrusion and 
sequestration of drug- thiol conjugates into a parasite vacuole.  Its role in metal resistance 
was confirmed by several transfection studies in laboratory strains (Papadopoulou et al., 
1994).  
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Mukhopadhyay et al. (1996) reported that arsenite/antimonite resistant L. 
tarentolae promastigotes overproduce trypanothione (TSH), a unique glutathione- 
spermidine conjugate found only in trypanosomatids. Ornithine decarboxylase (ODC) 
and γ-glutamylcysteine synthetase (γ-GCS) are the two rate-limiting enzymes present in 
the polyamine and glutathione biosynthetic pathways, respectively (Haimeur et al., 1999).  
These enzymes facilitate trypanothione overproduction, but increased levels of TSH 
alone are not sufficient to generate metal resistance (Figure 9).   
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Figure 9. Overview of Leishmania pathways involved in antimonial drug resistance 
(Decuypere et al., 2012)
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Reversion of metal resistance can be achieved by downregulation of TSH levels 
by specific γ-GCS or ODC inhibitors, such as  L-buthionine-(SR)-sulphoxime (BSO) and 
DL-α-difluor-o-methylornithine (DFMO), respectively (Haimeur et al., 1999).   Grondin 
et al. (1993) reported an increase in thiol levels as a result of an overexpression of either 
ODC or γ-GCS in L. tarentolae wild- type cells.  In addition, the overexpression of these 
specific inhibitors was almost equivalent to resistant mutants with the difference that the 
cells did not show arsenite resistance.  Whereas, when ODC or γ--GCS was co-
transfected with MRPA in wild type cells, arsenite resistance was observed (Haimeur et 
al., 1999; 2000).  The acquired resistance was reversed when transfectants were treated 
with BSO- a thiol depletory (El Fadili et al., 2005).  These studies established that MRPA 
and increased TSH levels act synergistically.  The limiting factor involved in both the 
drug transport conjugates and arsenite and/ or antimonite resistance was correlated to 
TSH availability (Ouellette et al., 1991).  The MRPA is localized in small vesicles, near 
flagellar pockets, that sequester arsenic/antimony–thiol conjugates and are later disposed 
outside the cell (Legare et al., 2001).  
Callahan et al. (1994) reported that overexpression of MRPA resulted in higher 
influx of antimony rather than higher efflux.  The difference of influx to efflux found 
might be the result of an inhibitory effect through associated membrane protein 
interactions.  This suggests that MRPA acts as an intracellular transporter rather than an 
efflux transporter and has a significant role in antimony resistance (Figure 9).   Dey et al. 
(1994) reported that the transport experiments in arsenite resistant L. tarentolea mutants 
showed the presence of an active efflux system.  However, the results did not correlate 
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with PGPA amplification in L. tarentolae or resulted in any significant accumulation of 
arsenite even after transfection. On the other hand, L. major transfectants showed a 
decrease uptake of antimony which serves as support when attempting to explain its 
resistance.  ABCC7-PRP1 is the second ABC transporter involved in antimony 
resistance.  When the PRP1 gene is overexpressed in pentamidine-resistant Leishmania 
cell lines, it confers significant cross-resistance to antimony, but the localization and 
mechanism by which this protein confers resistance needs to be determined (Ashutosh et 
al., 2007).  Other members of the ABCC subfamily, such as ABCC4, ABCC5 and 
ABCC7, also confer resistance to antimonials (Leprohon et al., 2009).  Recently, a new 
ABC half-transporter ABCI4 was characterized in L. major.  This transporter is localized 
both on the mitochondria and plasma membranes and is involved in efflux of Sb (III)-
thiol conjugate.  Overexpression of ABCI4 is a clear indicator of L. major antimony 
resistance (Manzano et al., 2013).  Therefore, ABCI4 can be considered a potential thiol-
X pump, which recognizes metal- conjugated thiols and confers antimony resistance in 
Leishmania (Manzano et al., 2013).   
Several studies in Indian L. donovani clinical isolates indicated higher TSH 
levels, which protect parasites from Sb(III) induced oxidative burst.  It was observed that 
thiol biosynthesis was much higher as compared to Sb(III) mediated thiol loss.  
Leishmania mexicana and Leishmania donovani were the first two parasites in which 
antimony transport studies were conducted in both the promastigotes and amastigotes 
stages using Pentostam (125Sb).  Inductively coupled plasma mass spectrometry (ICP-
MS) revealed the accumulation of two forms of antimony (Sb(V) and Sb(III)) in both 
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stages of parasite.  Nonetheless, accumulation of Sb(V) was found to be much more in 
axenic amastigotes in some species of Leishmania (Ashutosh et al., 2007).  It is known 
that Pentostam consists of Sb(V) complexed to gluconate and gluconate inhibits the 
uptake of Sb(V) in amastigotes.  Therefore, it was speculated that there should be some 
other mechanism for Sb(V) uptake inside the parasites.  Unfortunately, neither As(V) nor 
phosphate was able to compete with the uptake of Pentostam, which ruled out the 
possibility that Sb(V) uses an As(V) transporter.  Studies showed that Sb(III) and As(III) 
enter the cells via the same route, because the accumulation of Sb(III) is competitively 
inhibited by As(III), a related metal (Gourbal et al., 2004). 
 Gourbal et al. (2004) identified the first aquaglyceroporin or AQP1 in 
Leishmania.  This discovery was a breakthrough in the field of antimony resistance.  In 
Leishmania, to date, AQP1 is the only identified aquaporin which facilitates trivalent 
antimony [Sb(III)] transport.  In both stages of the parasite, AQP1 modulates drug 
sensitivity when overexpressed.  Several studies indicated that overexpression of AQP1 
gene in L. major produces hypersensitivity to Sb(III), whereas gene deletion makes the 
parasite resistant (Mandal et al., 2010).  After, the gene expression analysis of L. 
donovani field isolates from Nepal were completed, it was observed that the 
downregulation of AQP1 plays a major role in the reduced uptake of antimonite 
(Decuypere et al., 2005). 
Leishmania major aquaglyceroporin 1 (AQP1) is the major focus of my research 
project, so I will be describing in detail in the following sections the importance of AQP1 
in physiological roles and drug resistance in Leishmania.  During the life cycle of 
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Leishmania (described in section 1.4), the parasite faces many osmotic challenges during 
its transmission from vector (sandfly) to the mammalian host.  In order to combat these 
challenges, the parasite needs to regulate water and solute movements.  It is widely 
known that aquaporins, a special type of integral membrane proteins, facilitate the 
movement of water, and that they are ubiquitously present from bacteria to mammals.  It 
has already been shown that AQP1 plays a major role in providing promastigote with an 
osmotic fitness, which is required for successful transmission and establishes infection in 
the mammalian host (Gourbal et al., 2004). 
1.8 Membrane proteins 
Membrane proteins are the proteins which interact with biological membranes.  
They are anchored in the phospholipid bilayer.  Each phospholipid molecule has a 
hydrophilic head region and a hydrophobic tail region.  Membrane proteins are 
responsible for a variety of functions, including movement of molecules and ions across 
the membrane, elicitation of numerous signaling pathways, and membrane enzymatic 
activities (Lodish, 2000).  Singer and Nicolson,1972 classified these proteins into two 
classes: Peripheral and Integral membrane proteins.  
1.8.1. Peripheral membrane protein or extrinsic protein 
Peripheral membrane proteins are always facing the hydrophilic side of the 
phospholipid bilayer and do not interact with the hydrophobic core.  They are attached to 
the membrane by hydrophobic, electrostatic or other non-covalent interactions.  These 
proteins usually dissociate from the membranes when treated with solutions of high pH 
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or high salt concentration, but these conditions do not disrupt the phospholipid bilayer 
(Lodish, 2000). 
1.8.2. Integral membrane proteins or intrinsic proteins 
Integral membrane proteins are permanently attached to the membrane.  These 
proteins have hydrophobic side chains which interact with fatty acid acyl groups of the 
membrane phospholipids.  Integral membrane proteins are usually transmembrane 
proteins.  They extend out through the lipid bilayer so that one end is hydrophobic, in 
contact with the interior of the cell, while the other part is hydrophilic, exposed to the 
exterior of the cell.  Single pass membrane proteins can cross the membrane only once, 
whereas multiple pass membrane proteins can cross membrane several times (Figure 10).  
Aquaporins and aquaglyceroporins are the examples for this class of protein (Lodish, 
2000 Molecular Biology).  
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1.9 Parasite aquaporins  
Trypanosomes are unicellular and pathogenic parasites known to be one of the 
major causes of morbidity and mortality in tropical and subtropical regions worldwide.  
Leishmania species (leishmaniasis), Trypanosoma brucei (African sleeping sickness) and 
Trypansoma cruzi (Chagas disease) are the pathogens which belong to this group of 
parasites.  Trypanosomatid parasites have digenetic life cycles.  During transmission 
from the sandfly to the mammalian host, the parasite faces significant osmotic challenges.  
When the parasite resides inside the gut of the vector, it differentiates into infective forms 
and spreads the infection to specific organs.  In contrast, within the mammalian host, 
parasites need to find appropriate environments to escape the host defense mechanism, 
facilitating the pathogenicity pathway.  Osmotic signals are critical to cellular 
morphogenesis and migration in other organisms.  All living cells need to regulate water 
and solute movements efficiently in order to respond to osmotic signals (Mandal et al., 
2014).  The lipid bilayer membranes present in living cells are impermeable to water and 
other polar solutes, hence the need of employing membrane transporter (s) that permit the 
rapid regulated movements of water and non-solutes in and out of the cell by extra- and/ 
or intracellular stimulus.  In 1992, Peter Agre and his co-workers were the first to identify 
a channel- forming integral membrane protein, which facilitates water transport and is 
essential for all life processes.  The members of this channel protein are ubiquitously 
present in all organisms and are collectively called aquaporins (AQP).  Aquaporins 
(AQP) belong to the family of Major Intrinsic Proteins (MIP) that regulate the flow of 
water, glycerol and other uncharged solutes but are impermeable to charged particles and 
protons.  Water molecules move across the membrane channel in a single file.  AQPs are 
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distributed widely ranging from E.coli to humans.  Depending on the substrate 
specificity, the aquaporins family can be divided into two sub groups:  “orthodox 
aquaporins” that conduct only water and “aquaglyceroporins” that conduct glycerol and 
other small uncharged molecules along with water (Engel and Stahlberg 2002; Hub and 
de Groot 2008) (Figure 11 A and B).   
Members of the AQP superfamily are tetrameric proteins, and each monomer 
consists of six transmembrane helices and two short half helices which fold into the 
center of the channel (Jensen et al., 2002; Hub and de Groot 2008).  Interestingly, each 
monomer functions independently, and the central pore of the structure is impermeable to 
any solute.  The substrate specificity arises from the pore mouth size.  It was found that 
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the E.coli aquaglyceroporins GlpF pore mouth size is bigger than human orthodox 
aquaporin hAQP1 (Engel and Stahlberg, 2002).  One of the constriction regions at the 
pore mouth is known as the aromatic arginine (arg/R) constriction, and the other is 
known as the Aspargine-Proline-Alanine (NPA) region, which is located at the middle of 
the pore (Beitz, 2006).   The center of the pore is formed by two NPA motifs.  These 
NPA motifs act as a proton filter, which functions as a cap for the amino acids at the 
positive ends of helices B and E, and behave as hydrogen donors to the oxygen atoms of 
passing permeants (Mandal et al., 2014).  In mammals, 13 AQPs (0-12) have been 
identified so far (Hara-Chikuma and Verkman 2006).  Human AQPs play an important 
role in homeostasis of water, lung moistening, tears and saliva secretion, glycerol and fat 
metabolism.  It also facilitates cell migration, neural signal transduction, cell volume 
regulation and organellar physiology.  Several AQPs have been reported in many 
parasitic protozoa.  Plasmodium falciparum has a single aquaporin, Trypanosoma brucei 
contains three, Trypanosoma cruzi contains four, and five have been reported in 
Leishmania (Beitz, 2005).  Parasitic aquaglyceroporins are better water facilitators than 
bacterial GlpF, and they are responsible for the conduction of metalloids.  The only 
characterized AQP1 in Leishmania is LmAQP1, which conducts water and glycerol 
almost at the same rate.  LmAQP1 also transports glyceraldehydes, dihydroxyacetone and 
methyl glyoxyl (Figarella et al., 2007) and facilitates the uptake of metalloids such as 
arsenite and antimonite. 
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1.9.1 Role of AQP1 in Leishmania  
The L. major genome codes for five aquaporins: LmAQP1, LmAQPα, LmAQPβ, 
LmAQPγ, and LmAQPδ.  Bacterial aquaporins are closely related to LmAQP1 in L. 
major, whereas the other L. major aquaporins (LmAQP α-δ) share some properties with 
those of plant aquaporins (Song et al., 2014).  LmAQP1 also has significant permeability 
for water.  As described earlier, AQP1 is the sole reported Sb(III) facilitator.  
Amastigotes are more sensitive to Sb(III) than promastigotes, indicating that AQP1 may 
be differentially regulated in the two developmental stages of the parasite.  Disruption of 
one of the two AQP1 alleles in Leishmania major resulted in a 10-fold increase in 
resistance to Sb(III) (Gourbal et al., 2004).  Resistance to Sb(III) has been corroborated 
by downregulation of AQP1 mRNA levels in clinical isolates of drug- resistant L. 
donovani (Decuypere et al., 2005).  On the basis of these studies, it can be hypothesized 
that the AQP1 present in the plasma membrane constitutes the rate-limiting step in the 
uptake of the activated form of the antimonial drugs.  Overexpression of AQP1 makes the 
wild type parasites >100 fold more sensitive to Sb(III).  More importantly, 
overexpression of AQP1 can abolish the drug- resistant phenotype in drug-resistant 
isolates.  Therefore, AQP1 is instrumental in the successful treatment of leishmaniasis 
using antimonials.  In contrast to Plasmodium and Trypanosome AQPs, which are 
inhibited by mercury, AQP1 is a mercurial-independent channel (Uzcategui et al., 2008; 
Mukhopadhyay et al., 2011).  AQP1 also helps in the conduction of glycerol, 
methylglyoxal, glyceraldehydes, dihydroxyacetone (DHA), erythritol, and adonitol.  
Expression of LmAQP1 is limited to the flagellum of promastigotes;  in amastigotes, it is 
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found in the flagellar pocket, rudimentary flagellum and contractile vacuoles (Figarella et 
al., 2007) (Figure 12). 
 The presence of AQP1 in the flagella aids the parasite in volume regulation and 
osmotaxis, two important factors for overcoming the osmotic challenges the parasite 
faces during its life cycle.  Therefore, it is evident that AQP1 is critical to Leishmania 
physiology and drug resistance.  At physiological pH, the trivalent metalloids behave as 
molecular mimics of glycerol and are conducted through AQP channels.  It was reported 
that a single mutation in glutamate 152 (G152) of the extracellular C loop of AQP1 helps 
in the differentiation between glycerol and metalloids (Uzcategui et al., 2008) (Figure 
13).  
 Mukhopadhyay et al., 2011 reported that alanine 163 in loop C is present near the 
pore mouth and is significantly important for the function of the channel, as the alteration 
of alanine leads to channel function inactivation.  In the absence of transcriptional 
control, the Leishmania species primarily regulates its genes at the post-transcriptional 
and/or post-translational levels (Mandal et al., 2012).  Mandal et al. (2012) reported that 
mitogen activated protein kinase 2 (MPK2) positively regulates AQP1 stability through 
phosphorylation of the threonine 197 (T197) residue.  Aquaglyceroporin 1 (AQP1) 
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molecules phosphorylated at T197 are more stable compared to molecules without 
phosphorylation at T197.  Similarly, alteration of MPK2 destabilizes AQP1 because of 
the absence of phosphoryl transfer.  Interestingly, phosphorylation at T197 also affects 
localization of AQP1 and alters drug sensitivity and osmoregulatory activity of the 
parasite.  Evidence continues to suggest that AQP1 contributes significantly to the ability 
of the parasite to combat osmotic challenges during transmission from vector to host.   
1.10 Gene regulation in Leishmania 
Leishmania species have a haploid genome. It is organized into 36 chromosomes, 
which contains 911 RNA genes and 39 pseudo genes (Ivens et al., 2005).  The 
Leishmania genome encompasses 8272 genes encoding proteins.  The Old World and the 
New World Leishmania species have 36 and 34 or 35 chromosomes respectively 
(Wincker et al., 1996), which vary in size from 268 to 2,680 Kb (Uliana et al., 2007).  
The Leishmania genome is organized in the nucleus, which contains chromosomal and 
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episomal DNA. The genome is also comprised of kinetoplast, which contains 
independent replicating DNA molecules.  Leishmania is usually a diploid organism but in 
some cases, aneuploidy has also been observed.  For the genome-sequencing project, L. 
major has been used as a reference strain, which possesses three chromosome 1 
homologues. The genome size of L. major is 33.6 Mb with an overall of 59.7% GC 
content (Ivens et al., 2005).  In Leishmania, active retrotransposable elements are absent 
(Bringaud et al., 2006).  Sub-telomeric regions have a majority of repeat elements 
(Wickstead et al., 2003).  All Leishmania species contain a variety of hexameric repeat 
5’-TAGGGT-3’ and octameric repeat 5’-TGGTCATG-3’ in telomeres.  Both the 
hexameric repeats and octameric repeats are known as Leishmania conserved telomere-
associated sequences (LCTAS) (Fu and Barker, 1998).  In addition, Leishmania and 
Trypanosoma genomes are organized into long arrays of tandem coding sequences. These 
tandem coding sequences are positioned and transcribed into polycistronic primary 
transcripts (Ivens et al., 2005).  The directional gene clusters (DGCs) are not sized 
uniformly, varying from a few kb to more than 1.2 Mb (Uliana et al., 1996).  Sequences 
present between two divergent transcription units are called strand-switch regions 
(SSRs).  The nucleotide sequences present in the strand-switch regions do not show a 
particular consensus sequence for any RNA polymerase known promoter (Tosato et al., 
2001).  In general, transcription in trypanosomes and Leishmania by RNA polymerase II 
is quite unusual and unique. RNA polymerase II promoters encode approximately 120 
copies of the spliced leader RNA (SL RNA) gene (Gilinger and Bellofatto, 2001). These 
RNA polymerase II promoters are found in the intergenic sequences of the tandem array 
as mentioned above. In Leishmania, promoters for RNA polymerase I share similarities 
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with other organisms such as: insensitivity to α- amanitin, poor sequence conservation, 
and upstream regulation by repeated motifs (Yan et al., 1999; Martinez-Calvillo et al., 
2001).  Transcription of rRNA in Leishmania is driven by RNAP I.   The RNA 
polymerase III promoters are responsible for the transcription of tRNAs and small RNAs 
(Uliana et al., 1996). 
Regulation of gene expression is an array of various mechanisms that cells use in 
order to increase or decrease the production of specific gene products, such as RNA or 
proteins.  Leishmania is considered to be one of the most ancient eukaryotes.  Compared 
to other eukaryotes, Leishmania is unusual in terms of gene organization, transcription, 
and mRNA processing.  Three types of RNA polymerases play important roles in the 
transcription of Leishmania genes.  rRNA and tRNA genes are transcribed by RNA 
polymerase I and III, respectively, whereas RNA polymerase II, which is sensitive to α- 
amanitin, is involved in the transcription of protein-coding genes (Werbovetz, 2008).  A 
remarkable difference exists between gene expression mechanisms of Leishmania and 
those of the mammalian system, particularly in the processing of pre-mature RNA.  First, 
in mammals, transcription of protein coding genes is monocistronic, either carried out by 
RNA polymerase (RNAP) II or by each gene’s own transcriptional control, whereas in 
Leishmania, though RNAP II is involved, open reading frames arranged in long arrays 
are transcribed into polycistronic pre-RNA (RNA that contains multiple protein-coding 
sequences) that produces monocistronic RNA’s through post-transcriptional processing  
(Clayton and Shapira, 2007) (Figure 14).  
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Polycistronic units contain areas known as strand-switch regions (SSRs).  These 
polycistronic units can be convergent (opposite strands containing transcriptional operons 
converge towards SSRs) or divergent (opposite strands of SSRs diverge from one 
another), which depend entirely on the transcriptional orientation.  In Leishmania, 
divergent SSRs are associated with transcription initiation, whereas convergent SSRs are 
the sites for termination of transcription.  A second difference is that splicing in mammals 
is carried out by removal of introns from the same RNA molecule, that is, through the 
cis-splicing mechanism.  In Leishmania, a trans-splicing mechanism and polyadenylation 
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are the two coupled cleavage reactions, which are responsible for the processing of 
polycistronic pre-mRNA.  Trans-splicing mechanisms occur when exons are fused from 
two different RNA molecules and lack the presence of introns (Figure 14) (Haile and 
Papadopoulou, 2007). 
During a trans-splicing reaction, a small capped RNA, known as the splice leader 
RNA (SL RNA), which is 39-41 nucleotides in length, is added to the 5’ end of all known 
protein-coding RNAs, followed by introns of variable length which can be folded into 
two stem loops separated by a single strand region (Clayton and Shapira, 2007). Trans-
splicing also occurs through two-step trans-esterification, forming a Y- shaped structure 
rather than the lariat formed in eukaryotes (Figure 15).   
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The presence of a hypermodified cap structure, known as cap 4, is the most 
distinctive feature of SL RNA because the 4 nt present after the 7- methylguanosine 
(m7G) are modified.  Therefore, the addition of SL performs two functions: (a) SL 
sequence and polyadenylation together help in the separation of polycistronic transcripts, 
and (b) SL sequence provides a cap to mRNA (Liang et al., 2003).  Trans-splicing signals 
are usually U-rich polypyrimidine (poly (Y)) tracts, preceded by an AG splice acceptor 
site 50-100 nt upstream of the translational start codon.  In Leishmania, the 3’ splice 
acceptor site is an AG dinucleotide, which is present downstream to the polypyrimidine 
tract (Haile and Papadopoulou, 2007).  The polypyrimidine tracts within intergenic 
regions play important roles in the coupling of these processes in Leishmania and 
trypanosome transcripts.  Hug et al. (1994) reported that mutation in the poly (Y) tract 
leads to an aberrant poly (A) site choice.  There are several gaps in the understanding of 
pre-mRNA processing in trypanosomes.  The major question is how the selection of exact 
3’ splice site upstream of the translation initiator start codon takes place.  It was 
suggested that the factors required for pre-mRNA processing in Leishmania are marked 
by spliceosome machinery after the 3’splice site region; these factors may also direct 
polyadenylation upstream (Matthews et al., 1994). Studies by Lebowitz et al. (1993) 
suggested that the poly (A) site shifts 400-500 nt upstream of the new splice site 
whenever the position of the downstream splice site is altered.  Therefore, selection of the 
poly (A) site is specified by the position of the downstream splice acceptor site in 
Leishmania.  Since trans-splicing and polyadenylation are coupled processes, 
polyadenylation sites are present 100-400 nt upstream from the trans-splicing signal and 
are dependent on downstream splicing (Liang et al., 2003). These post-transcriptional 
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RNA processing reactions are essential to mRNA maturation but may also help to control 
gene expression.  
In eukaryotes, internal ribosome entry sites (IRES) and upstream ORFs present in 
5’UTRs of mRNA are critical to regulation of mRNAs translation in response to 
environmental stimuli (Meijer and Thomas, 2002).  The 5’- untranslated regions 
(5’UTRs) of mRNA are generally short in Leishmania because of the lack of IRES and 
upstream ORFs (Meijer and Thomas, 2002), whereas the sequences present within the 3’-
untranslated regions (3’UTR) regulate differentially expressed genes in Leishmania and 
are reported to be involved in stage-specific post-transcriptional gene regulation 
(Argaman et al., 1994).  Unusually long 3’UTR sequences and lack of promoter elements 
for RNA polymerase II provide evidence of the molecular basis for this type of control.  
In general, gene regulation in trypanosomes occurs via post-transcriptional and/or post-
translational mechanisms, which include mRNA processing, mRNA degradation and 
translational efficiency, and protein processing, modification and stability (Papadopoulou 
et al., 2003).  Regulatory mechanisms affecting global and specific gene expression in 
Leishmania are activated due to extreme environmental changes during the conversion 
from promastigotes to amastigotes.  In Leishmania chagasi, studies reported that the 
regulation of genes encoding major surface protease (MSPL) is mediated by a 202 nt 
region present within the MSPL 3’UTR, which confers an increase in mRNA stability 
(Purdy et al., 2005).  Kelly et al. (2001) observed that in L. major, stage-specific 
leishmanolysin genes (GP63) are under the influence of sequences within the 3’UTR.  
Several studies suggest that translation efficiencies are governed by the sequences present 
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in the 3’UTR (Papadopoulou et al., 2003).  Certain experimental evidence suggested that 
the 3’UTR bearing heat shock protein (HSP70) transcripts (HSP70-I) were found to be 
associated with ribosomes in promastigotes at normal and heat-shock temperatures, 
whereas HSP70-II transcripts appeared to preferentially translated at heat-shock 
temperatures but not at 26°C (temperature inside sandflies) (Folgueira et al., 2005).  In 
trypansomatids, the first evidence of the presence of sequences within 770 nt of the 
amastin 3’UTR was reported, implicating the involvement of these sequences for stage-
specific regulation.  On the basis of the presence of sequences in amastin 3’UTR, 
Papadopoulou et al. (2003) identified the presence of 450 nt 3’UTR element in the 
amastin mRNA in L. major and its role in regulating mRNA translation by enabling the 
3’UTR element to bind tightly with polysomes in a stage-specific manner.  It was shown 
that regulation through the 450 nt element is triggered in response to heat shock.  
However, this element is not conserved in all the amastigote specific transcripts.  Stage-
specific gene expression can be controlled either at the level of mRNA stability or at the 
translation level by a bipartite mechanism, which involves 3’UTR elements that mediate 
regulation at the level of mRNA abundance and translation, respectively, in Leishmania 
(Papadopoulou et al., 2003).  It was reported that this 3’UTR element belongs to a new 
family of extinct short retroposons, small-interspersed degenerate retroposons (SIDER1) 
(Papadopoulou et al., 2003).  The other two amastin transcripts bearing a 3’UTR element 
of 500-550 nt (Rochette et al., 2005) were parts of another SIDER subfamily, SIDER 2, 
which is distinct from SIDER1 in terms of promoting mRNA stabilization.  The 3’UTR 
elements classified to date in Leishmania are different from the other known regulatory 
elements previously reported in eukaryotes, including trypanosomes.  It was found that 
   39
regulation of gene expression is complex in Leishmania and is controlled by a diversity 
of mechanisms, as the transcripts contain more than one regulatory element in the 
3’UTR.  In trypanosomatids, RNA-binding proteins (RBP) are key factors in regulating 
gene expression.  Over one hundred RBPs have been predicted to exist in trypanosomes, 
based on the presence of canonical RNA-binding domains:  RNA recognition motif 
(RRM), CCCH zinc fingers, and Pumilio or PUF domains.  Most of the characterized 
RBPs control mRNA abundance by stabilizing the target transcript (De Gaudenzi et al. 
,2011) .  In trypanosomatids, although indirect results suggest that some proteins cause 
degradation of target transcripts, this has never been shown directly (Erben et al., 2014). 
Phosphorylation, methylation, acetylation or glycosylation are some of the post-
translational events, which are responsible for the functional changes in proteins. 
Furthermore, ubiquitination, another post-translational event, is responsible for the 
proteasome-dependent degradation pathway of protein.  Several post-translational 
modifications have been reported in trypanosomatids but post- translational regulation of 
proteins has not yet been abundant and there are missing links. In Leishmania, 
environmental changes lead to modulation in protein phosphorylation or protein kinase 
activities.  Studies reported that in virulent L. donovani promastigotes, heat stress 
stimulates the alteration in protein phosphorylation (Salotra et al., 2000) whereas in L. 
pifanoi, protein tyrosine phosphorylation is activated by acidic pH (Rivero-Lezcano et al., 
1997).  In L. major, endogenous membrane protein phosphorylation have been observed 
during the differentiation from promastigotes to metacyclic forms (Hermoso and Jaffe 
1993).  In L. mexicana, Wiese et al., 2003 showed that mitogen-activated protein kinase 
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kinase (MAPKK) homologue which is regulated by phosphorylation is involved in the 
regulation of flagellar assembly and cell size.  There are no reports about such regulations 
of aquaporins in trypanosomatids.  Since, AQP1 is directly related to drug resistance 
understanding the regulation will help us to combat resistance more efficiently.  
1.11 Rationale of the study 
  The long-term goal of this project is to decipher the signaling cascade of AQP1 
channel regulation in order to combat antimonial resistance.  The current objectives of 
this project are to identify the immediate players involved in the regulation of AQP1 
channel function.  Our central hypothesis is that the Leishmania aquaglyceroporin AQP1 
is regulated at the post-transcriptional and post-translational levels through interaction 
with other cellular components.  We plan to dissect this interplay step-by-step.  We 
demonstrated that Leishmania MAPK2 positively regulate AQP1 and localized it to the 
pellicular membrane by phosphorylating a cytosolic loop D residue Threonine 197 
(Mandal et al., 2012).  The proposed work has provided an enhanced understanding of 
the fundamental mechanisms by which an aquaglyceroporin helps a parasite to sense its 
environment, including antimonial exposure.  These are unchartered areas of parasite 
biology and physiological functions of aquaglyceroporins.  The following specific aims 
have examined how AQP1 is regulated at the a) post-translational and b) post-
transcriptional levels: 
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1.11.1 Deciphering the mechanism (s) of regulation of AQP1 at the post-
translational level:   
 Detailed analysis of AQP1 protein sequence by unique software and our data 
revealed evidence of ubiquitination sites.  Inhibitory and site-directed mutagenesis 
studies along with tandem affinity tag methodology were used to dissect these 
mechanisms.  The split-ubiquitin membrane yeast two hybrid systems was an additional 
approach to unravel the AQP1 interactome. 
1.11.2 Elucidating the mechanism (s) of post-transcriptional regulation of AQP1: 
 Our data indicate that the level of AQP1 expression is regulated at the post-
transcriptional level by the 3’UTR and is species-specific.  Mechanisms were studied 
through luciferase reporter assay. 
  The Mukhopadhyay’s group was the first to identify and characterize the 
Leishmania aquaglyceroporin AQP1 and its involvement in parasite physiology.  
Identification of specific novel features of this AQP has been a major contribution to the 
Leishmania and aquaporin fields as represented by the fact that our work was featured 
by “International Innovation” in their latest special edition on “Women in Science”- A 
Passion for Progress.  Collectively, these studies explore a novel aspect of parasite 
biology and a unique aquaglyceroporin.  The novel aspect of unique aquaglyceroporin 
will have a positive impact on our understanding of Leishmania physiology and how it 
helps a parasite to survive in a stressful environment and facilitate antimonial uptake.  
Our evidence suggests that AQP1 is more intricately involved with various cellular 
machinery and signal transduction than previously thought.  Since AQP1 is essential for 
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parasite survival, our eventual long-term goal is to target AQP1 and its regulatory 
elements to resolve antimonial resistance and to identify new targeted interventions. 
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2.1. Introduction 
Leishmaniasis is a vector-borne parasitic disease caused by protozoa of the genus 
Leishmania.  The disease is spread to humans and other mammals by the bite of the 
female phlebotomine sand fly.  Leishmaniasis includes two major diseases, cutaneous 
leishmaniasis (CL) and visceral leishmaniasis (VL) or kala-azar, caused by more than 20 
different Leishmania species.  The disease is endemic in parts of 88 countries in five 
continents – the majority of the affected countries are in the tropics and subtropics.  
Approximately 2 million new cases occur annually, of which 1.5 million are categorized 
as CL and 500,000 as VL (Frezard et al., 2009).  First-line treatment against this disease 
consists of antimony V (SbV)-containing drugs, Pentostam or Glucantime.  Drug 
resistance, however, is a major problem in endemic areas.  More than 60% of patients in 
eastern India are infected with drug-resistant Leishmania parasites (Sundar et al., 2000).  
The Mukhopadhyay group identified the first Leishmania aquaglyceroporin (AQP1) and 
demonstrated that modulation of AQP1 determines the sensitivity of the parasite to 
antimonial drugs (Gourbal et al., 2004; Marquis et al., 2005), which led us to propose that 
a portion of the pentavalent antimonial drug (SbV) is reduced to trivalent antimony 
(SbIII) in the macrophage and transported to amastigotes by AQP1.  Drug-resistant field 
isolates from India (Mandal et al., 2010) and Nepal (Decuypere et al., 2005) showed 
downregulation of AQP1.   Because AQP1 is now being used as one of the major drug 
resistant markers in the endemic regions (Mishra et al., 2012; Kazemi-Rad et al., 2013; 
Rai et al., 2013), identifying the regulatory mechanisms of AQP1 has the potential to help 
combat antimonial resistance.  AQP1, however, is an adventitious drug transporter.  The 
physiologic functions of this unique AQP are osmoregulation and osmotaxis, which have 
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crucial roles in parasite transmission (Figarella et al., 2007).  Our recent experiments in 
the sand fly Lutzomyia longipalpis revealed that L. donovani overexpressing AQP1 is 
more persistent and hyperactive in later stages (e.g., days 11-13) of fly infection 
compared to wild-type (unpublished data).  AQP1 is indispensable for the parasite as it is 
responsible for guided osmotaxis for coping with the challenges of osmotic stresses. 
Therefore, manipulation of AQP1 expression levels may have bipartite effect: (i) 
induction of AQP1 expression may resensitize drug resistant parasites and curtail the 
antimony toxicity by reducing the current dosage regime, and (ii) inhibition of AQP1 
expression may be deleterious to the parasite’s survival and transmission.   
The Mukhopadhyay group dissected the substrate specificity of the channel and 
demonstrated that glutamate 152 in the flexible loop C was responsible for selecting 
between antimony and glycerol (Uzcategui et al., 2008).  They defined the pore mouth of 
AQP1 and showed that alanine 163 and threonine 164 in the extracellular flexible loop C 
are located very close to the pore mouth (Mukhopadhyay et al., 2011).  AQP1 is the first 
AQP to be exclusively localized in the flagellum of any organism (Figarella et al., 2007).  
The trypanosomatid flagellum is necessary for parasite migration and invasion of host 
tissues. Furthermore, the flagellum is proposed to regulate processes such as secretion 
and endocytosis in the flagellar pocket and may be enriched in proteins involved in 
environmental or nutritional sensing (Gull, 1999; Bastin et al., 2000; Hill 2003; Vaughan 
and Gull, 2003).  Leishmania promastigotes experience acute changes in osmolarity 
while thriving inside the sand fly gut or as metacyclics swimming towards the fly's 
proboscis.  Additionally, the parasite faces temperature stress during transmission from 
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the sand fly to the vertebrate host and pH stress while living inside the macrophages in 
the mammalian host.  Antimony exposure is yet another stress when the host is treated 
with Pentostam or Glucantime.  How the parasite senses these crucial environmental 
changes and transduces these sensations at the molecular level remain gaps in our 
understanding of parasite biology.  We recently showed that species-specific antimonial 
sensitivity of Leishmania is driven by post-transcriptional regulation which is exclusively 
mediated by its 3’UTR (Mandal et al., 2015). 
Additionally, we previously demonstrated that the induction of Mitogen Activated 
Protein Kinase 2 (MPK2) from Leishmania increased drug sensitivity by stabilizing 
AQP1 by phosphorylation, whereas a MAPK2 null mutant was resistant to antimonite.  
This T197-specific phosphorylation increased the half-life of the channel and also 
localized AQP1 to the pellicular membrane, giving the parasite a formidable advantage to 
combat osmotic challenges during and after transmission (Mandal et al., 2012).  We also 
showed that when a variant MPK2 (MPK2K42A), unable to make the phosphoryl transfer, 
was overexpressed with AQP1, AQP1 was highly destabilized.  We speculated that this 
may be due to a dominant negative effect (Mandal et al., 2012).  In this study, we show 
that this MPK2K42A mediated accelerated destabilization of AQP1 is due to the presence 
of a critical lysine 12 (K12) at the disordered cytosolic N-terminus of the protein.  When 
K12A/R-AQP1 was overexpressed with MPK2K42A, the Sb(III) facilitator was  highly 
stabilized.  The promastigotes co-expressing these altered proteins were hypersensitive to 
Sb(III) and accumulated more of the metalloid when compared to AQP1 alone.  AQP1 
remained confined to the flagellar membrane. 
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2.2. Materials and methods 
2.2.1. Strains and media 
Leishmania donovani strain LdBob was a kind gift from Dr. Stephen M. 
Beverley, Washington University School of Medicine.  Leishmania promastigotes were 
grown and maintained in M199 medium as described previously (Mandal et al., 2012).  
Briefly, the promastigotes were grown at 25°C in M199 medium supplemented with 10% 
heat inactivated fetal bovine serum (Hyclone), 25mM HEPES (Sigma), 12mM 
NaHCO3(Sigma), 2mM glutamine (Life technologies), 1X RPMI 1640 vitamin mix 
(Sigma), 10 μM folic acid (Sigma), 100 μM adenosine (Sigma), 7.6 mM hemin (Sigma), 
50U/ml penicillin and streptomycin (Life technologies). The pH was adjusted to 6.8 at 
25°C with 1M NaOH.  Promastigotes were maintained in 5ml of M199 medium in a T25 
flask (Corning) by serially passaging at a 1:50 dilution in the same medium after every 3 
days (Goyard et al., 2003).  Table 1 details the constructs, strains and transfectants used 
in this study. 
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Table 1. Plasmids and strains 
Plasmids/Strains Genotype/Description Reference 
Plasmids   
pSP72αhygroα Leishmania expression vector (Papadopoulou 
et al., 1992; 
Gourbal et al., 
2004) 
pSP72αneoα Leishmania expression vector (Papadopoulou 
et al., 1992; 
Gourbal et al., 
2004) 
AQP1WT-
pSP72αhygroα 
L. major wild type AQP1 gene cloned into the 
XbaI-HindIII sites of pSP72αhygroα 
(Figarella et al., 
2007) 
AQP1K12A-
pSP72αhygroα 
Site directed mutagenesis of the Lys12 codon to 
an alanine codon in the AQP1 gene of AQP1WT 
-pSP72αhygroα 
This study 
AQP1K12R-
pSP72αhygroα 
Site directed mutagenesis of the Lys12 codon to 
an arginine codon in the AQP1 gene of 
AQP1WT -pSP72αhygroα 
This study 
MPK2WT- 
pSP72αneoα 
L. major wild type MPK2 gene cloned into the 
XbaI-HindIII sites of pSP72αneoα 
(Mandal et al., 
2012) 
MPK2K42A-  
pSP72αneoα 
Site directed mutagenesis of the  Lys42 codon 
to an alanine codon in the MPK2 gene of 
MPK2WT -pSP72αneoα 
(Mandal et al., 
2012) 
 
Strains 
  
Leishmania   
LdBOB L. donovani wild type strain (Goyard et al., 
2003) 
Vector alone LdBob co-transfected with pSP72αhygroα and 
pSP72αneoα 
This study 
AQP1WT LdBob co-transfected with AQP1WT-
pSP72αhygroα and pSP72αneoα 
This study 
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AQP1K12A LdBob co-transfected with AQP1K12A-
pSP72αhygroα and pSP72αneoα 
This study 
AQP1K12R LdBob co-transfected with AQP1K12R-
pSP72αhygroα and pSP72αneoα 
This study 
MPK2WT LdBob co-transfected with MPK2WT-
pSP72αneoα and pSP72αhygroα 
This study 
MPK2K42A LdBob co-transfected with MPK2K42A-
pSP72αneoα and pSP72αhygroα 
This study 
AQP1WT + 
MPK2WT 
LdBob co-transfected with AQP1WT-
pSP72αhygroα and MPK2WT-pSP72αneoα 
This study 
AQP1K12A + 
MPK2WT 
LdBob co-transfected with AQP1K12A-
pSP72αhygroα and MPK2WT-pSP72αneoα 
This study 
AQP1K12R + 
MPK2WT 
LdBob co-transfected with AQP1K12R-
pSP72αhygroα and MPK2WT-pSP72αneoα 
This study 
AQP1WT + 
MPK2K42A 
LdBob co-transfected with AQP1WT-
pSP72αhygroα and MPK2K42A-pSP72αneoα 
This study 
AQP1K12A + 
MPK2K42A 
LdBob co-transfected with AQP1K12A-
pSP72αhygroα and MPK2K42A-pSP72 αneoα 
This study 
AQP1K12R + 
MPK2K42A 
LdBob co-transfected with AQP1K12R-
pSP72αhygroα and MPK2K42A-pSP72αneoα 
This study 
 
2.2.2. Oligonucleotide-directed mutagenesis 
Wild type Leishmania AQP1 gene was cloned in pGEMT-Easy vector as 
described previously (Gourbal et al., 2004).  Alterations were created using the 
Quickchange site directed mutagenesis kit (Stratagene).  In this process, supercoiled 
double-stranded DNA(dsDNA) vector with a gene of interest was used as a template.  
Two oligonucleotide primers containing the desired mutation were used, each 
complementary to the opposite strands of the vector.  Pfu Turbo DNA polymerase used in 
the polymerase chain reaction (PCR) replicates both plasmid strands without 
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displacement of the mutagenic oligonucleotide primers. Integration of mutated primers 
generates a mutated plasmid containing staggered nicks.  Then, the PCR product was 
treated with Dpn I, an endonuclease enzyme specific for methylated and hemimethylated 
DNA.  This enzyme is particularly used for the digestion of parental DNA template and 
for the selection of newly synthesized DNA containing mutation.  The nicked, circular 
dsDNA was transformed in XL1-Blue supercompetent cells (Agilent), which helps in the 
repair of nicks in the mutated plasmid (Figure 16).   
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The putative ubiquitination site lysine 12 (K12) of AQP1 was altered to alanine 
(A) or arginine (R).  The mutagenic oligonucleotides used for both strands and the 
respective changes introduced (underlined) are as follows: K12A, 5’- 
GAGGACCAACACGAGAGTGCGCGAAACTTCATGTCGCAG-3’ (sense) and 5’- 
CTGCGACATGAAGTTTCGCGCACTCTCGTGTTGGTCCTC-3’ (antisense); K12R, 
5’- GACCAACACGAGAGTAGGCGAAACTTCATGTCG-3’ (sense) and 5’- 
CGACATGAAGTTTCGCCTACTCTCGTGTTGGTC-3’ (antisense).  Each mutation 
was confirmed by sequencing the entire gene (Eton biosciences, North Carolina, USA).  
Altered AQP1 was digested with HindIII and Xba I and cloned into the same sites of 
pSP72αhygroα.  Altered Leishmania mitogen activated protein kinase 2 (MPK2) used in 
this study was described previously (Mandal et al., 2012).  Briefly, Leishmania major 
MPK2 was PCR amplified from genomic promastigote DNA and the PCR product was 
gel purified. The resulting fragment was cloned into pGEM-T Easy vector (Promega), 
and sequenced.  The MPK2/pGEM-T Easy construct was subcloned into the yeast 
expression vector pYES2 (Life Technologies) followed by digestion with HindIII and 
XbaI and cloned into the same sites of pSP72-αneoα giving rise to MPK2-pSP72αneoα 
(Mandal et al., 2012).  
2.2.3. Transfection of AQP1 and MPK2 in Leishmania  
Transfection of AQP1-pSP72αhygroα and MPK2-pSP72αneoα into LdBob 
promastigotes were accomplished as described previously (Mandal et al., 2012).  Briefly, 
5ml of stationary phase promastigote cells were centrifuged at 3000 rpm for 5 min at 
room temperature.  Cells were washed once with HEPES-NaCl buffer.  Cell pellet was 
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resuspended in HEPES-NaCl buffer.  2 X 108cells/ml were used for transfection of 2 μg 
DNA.  Cells containing DNA were electroporated in a cuvette (0.4 cm, Biorad) using 
Gene Pulsar (Biorad).  Cells were immediately pipetted into T25 flask (Corning) 
containing 5 ml of M199 medium.   All altered MPK2 and AQP1 constructs were 
transfected one at a time for each strain created for this study.  All transfectants were 
maintained in the presence of 30 mg ml-1hygromycin B and 60 mg ml-1 geneticin. 
2.2.4. Antimony sensitivity assay 
Antimony sensitivity profiles of the promastigotes were carried out as described 
previously (Mandal et al., 2012).  Briefly, 1x 107 log phase cells were diluted 10 fold in 
culture medium (M199) containing increasing concentration of Sb(III) in the form of 
potassium antimonyl tartrate.  Cell growth was monitored after 72 h at A600 using a 
microplate reader (Spectramax 340, Molecular Devices).  EC50 was calculated from the 
linear regression curve of % viability of cell at each concentration of Sb(III).  Each assay 
was performed at least three times in triplicates.  Errors bars were calculated from the 
mean ± SE (Sharma et al., 2015). 
2.2.5. Uptake assay 
Uptake assay was performed using log phase promastigotes.  Cells were washed 
twice with PBS, pH 7.4 (Thermo scientific) and resuspended in PBS at a density of 108 
cells ml-1.  Cells were incubated with 10 µM potassium antimonyl tartarate [Sb(III)] for 
10 min at room temperature.  A 200 µl of cell suspension was filtered through 
nitrocellulose membrane and the membrane was washed with 5ml of ice-cold PBS.  The 
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membranes were digested with 0.4 ml of concentrated HNO3 (69–70%; EM Science) for 
one hour at 70°C, allowed to cool to room temperature, and diluted with high-pressure 
liquid chromatography grade water (Sigma) to produce a final concentration of 
approximately 3% HNO3.  Samples were analyzed by PerkinElmer SCIEX ELAN® 
DRC-e inductively coupled plasma mass spectrometer.  Standard solutions were made in 
the range of 0.5–10 ppb in 3% HNO3 using antimony standards (Ultra Scientific).  Each 
transport experiment was repeated at least three times with duplicate samples.  Error bars 
were calculated from the mean + SE. ( Sharma et al., 2015). 
2.2.6. Cell volume measurements  
  Swelling is the first response of any animal cell exposed to a hypo-osmotic stress. 
Swollen cells start to expel several electrolytes and amino acids via active transporters to 
create a hyperosmotic zone near the vicinity of the cell membrane.  This hyperosmotic 
zone drags the water out from the cells exclusively through aquaporins allowing the cells 
to regain their cell volume.  This phenomenon is known as regulatory volume decrease 
(RVD) (Figure 17).   
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 Mukhopadhyay’s lab have shown that rate of RVD is directly proportional to the level of 
LmAQP1 expression in a Leishmania (Figarella et al., 2007).  Relative changes in cell 
volume were measured upon introduction of hypo-osmotic stress as described previously 
(Mandal et al., 2012).  Briefly, log phase promastigotes were washed twice with PBS and 
resuspended at a density of 109 cells ml-1.  A 100µl of cells were transferred to the 
microtiter plate and hypo-osmotic shock was induced by dilution of the isotonic cell 
suspension with an equal volume of deionized water and the absorbance at 550 nm was 
recorded every 15 sec for 3 min in a microplate reader (Spectramax 340, Molecular 
Devices).  A decrease in absorbance corresponds to an increase in cell volume and vice 
versa.  Isosmotic control experiments consisted of dilution of cell suspensions with 
appropriate volumes of isosmotic buffer.  All hypo-osmotic shock experiments were 
conducted at a final osmolarity of 150 mOsm (1:1 dilution of isosmotic buffer and water).  
Experiments were repeated for three times in triplicate.  Error bars were calculated from 
the mean ± SE. 
2.2.7. Flagella and pellicular membrane isolation and Immunoblotting  
The flagellar and pellicular plasma membrane fractions from LdBob wild type 
promastigotes or transfected with vector alone, altered AQP1 and MPK2 were isolated as 
described previously (Mandal et al., 2012).  All procedures were performed at 4°C. 
Briefly, flagellar membrane fractions were isolated using 150 ml of 3 days old 
promastigote culture.  Cell were washed twice with ice-cold Buffer A (25 mM Tris-HCl, 
pH 7.4, 0.2 mM EDTA, 5 mM MgCl2, 12 mM β-mercaptoethanol, and 0.32 M sucrose) 
and resuspended in 3 ml of ice-cold sonication buffer [Buffer A, 1% BSA, 0.1 mM CaCl2 
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and Complete Protease Inhibitor Cocktail (Roche)].  Flagella were detached without 
lysing the body of the cells by sonication on ice using three pulses of 1s each, with 25% 
amplitude.  Flagellar preparation was isolated from the supernatant by centrifuging at 700 
g for 15 min followed by pelleting at 6800 g for 20 min.  The pellet was resuspended in 
Buffer B (25 mM Tris-HCl, pH 7.4, 0.2 mM EDTA, 5 mM MgCl2, 12 mM β-
mercaptoethanol) and loaded onto 0.8 M sucrose cushion and centrifuged at 1080 g for 
20 min.  The upper layer was removed and overlaid on a discontinuous gradient of 
sucrose (1.65 M and 1.85 M) and ultracentrifuged at 133 000 g for 3 h.  The interphase 
flagellar layer was removed, resuspended in Buffer A and ultracentrifuged at 143 000 g 
for 45 min.  Depending on the size, pellet was resuspended in 60 – 80 μl of Buffer A.  
Pellicular membrane fractions were isolated as follows.  3 days old promastigote cells 
(150 ml culture) were harvested.  Cells were washed with Buffer C (75 mM Tris-HCl, pH 
7.4, 140 mM NaCl, 11 mM KCl), then resuspended in Buffer D [10 mM HEPES, pH 7.4, 
10 mM KCl, 1 mM MgCl2, 400 mM mannitol, and Complete Protease Inhibitor Cocktail 
(Roche)] and broken by sonication using five pulses of 10 s each with 50% amplitude.  
Unbroken cells and cell debris were removed by centrifugation at 3000 g for 10 min.  The 
supernatant was centrifuged at 17 000 g for 40 min to remove organelles and other 
intracellular membranes followed by centrifugation at 140 000 g for 1 h.  The pellet, 
highly enriched in plasma membrane fraction, was washed and suspended in 1 ml of 
Buffer E (75 mM HEPES, pH 7.4, 150 mM KCl, 2 mM MgCl2).  Protein contents of 
either the pellicular membrane enriched or flagellar fractions were determined by the 
BCA protein assay kit (Pierce).  The total protein contents of either the flagellar or 
pellicular plasma membrane fractions were determined by a filter assay method 
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(Schaffner and Weissmann 1973).  For immunoblot analysis, 25 μg of flagellar protein 
samples and 45 μg of pellicular protein samples were electrophoresed into a 12% SDS-
polyacrylamide gel, and electro-blotted onto nitrocellulose membrane (Whatman).  The 
blot was incubated with affinity-purified AQP1 antiserum as described previously 
(Figarella et al., 2007).  The labelling was visualized with horseradish peroxidase-
conjugated goat anti-rabbit serum (Sigma) using a Western Lightning 
Chemiluminescence Reagent Plus system (PerkinElmer). 
 Rabbit polyclonal anti-peptide antibody (anti-LmxMPK2) was used to detect 
MPK2 expression in Leishmania.  For analysis of LdBob lysates, ~2 X 107 cells were 
boiled in 100 μl of lysis buffer [1X PBS, 0.1% (w/v) SDS, 50 mM DDT, 50 μM 
leupeptin, 25 μM Nα-p-Tosyl-L-lysine chloromethyl ketone, 1 mM 
phenylmethanesulfonyl fluoride, 10 mM 1,10-phenanthroline, and 1X Laemmli sample 
buffer].  Twenty microliter of each sample were subjected to 12% SDS-PAGE and 
electro-blotted onto nitrocellulose membrane.  The blots were incubated with the anti-
LmxMPK2 antibody (1:100 dilution) overnight at 4°C.  The labeling was visualized with 
horseradish peroxidase-conjugated goat anti-rabbit serum (Sigma) using a Western 
Lightning Chemiluminescence Reagent Plus system (PerkinElmer) (Mandal et al., 2012) 
2.2.8. Treatment with proteosome inhibitor and immunoblot 
Promastigotes over expressing AQP1WT or co-overexpressing and AQP1WT + 
MPK2K42A were treated with the 10 μM proteasome inhibitor MG132 and incubated for 
48 hrs.  Total plasma membrane protein was isolated as described above for pellicular 
membranes.  The total protein content of the membranes was determined using filter 
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assay method (Schaffner and Weissmann 1973).  For immunoblot analysis, 50 μg of total 
membrane protein sample was electrophoresed into a 12% SDS-polyacrylamide gel, and 
electroblotted onto nitrocellulose membrane (Whatman).  The blot was incubated with 
affinity-purified AQP1 antiserum as described previously (Figarella et al., 2007).  The 
labeling was visualized with horseradish peroxidase-conjugated goat anti-rabbit serum 
(Sigma) using a Western Lightning Chemiluminescence Reagent Plus system 
(PerkinElmer).  Cells treated with MG132 were also examined for antimonite sensitivity 
and Sb(III) accumulation as described above.  
For determining EC50, MG132 treated cells for 48 h were washed, diluted to 2 x 
106 cells/ml in fresh medium with MG132 and, treated with different concentrations of 
potassium antimonyl tartrate.  EC50 was determined by counting cells manually in a 
hemocytometer.  For Sb(III) uptake MG132 treated cells were washed once with PBS+10 
µM MG132, and resuspended in PBS at a density of 108 cells ml-1.  Sb(III) accumulation 
in whole cells was measured as described above in section 2.2.5.     
2.2.9. Immunofluorescence analysis 
Late-log-phase LdBob promastigotes (5X105cells) were fixed in 4% 
paraformaldehyde/PBS overnight at 40C.  The cells were washed twice with PBS, 
transferred to teflon coated immunofluorescence slides (Polysciences), and permeabilized 
with 0.1% TritonX-100, 50 mM Na2PO4, 50 mM glycine, pH 7.2, for 2 min.   After 
blocking with 1% bovine serum albumin (BSA) in PBS for 30 min, cells were incubated 
for 1 h at room temperature with AQP1 anti-serum (1:300 in 1% BSA).  The primary 
antibody was removed by washing three times with 1% BSA followed by incubation with 
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the monoclonal anti-tubulin antibody (Sigma–Aldrich) 1:500 for another hour.   After 
three washes with 1% BSA, the slides were incubated with Alexa Fluor®488-conjugated 
goat anti-rabbit IgG (Life Technologies) (1:1000 in 1% BSA) and Alexa Fluor®594-
conjugated goat anti-mouse IgG (Life Technologies) (1:2000 in 1% BSA) for 1 h.  
Finally, the cell nuclei were stained with DAPI (0.1 mg ml−1final concentration) 
(Sigma–Aldrich) for 10 min, the slides were washed three times with 1% BSA, and once 
with sterile water.  The slides were mounted in Vectashield®Antifade Mounting Medium 
(Vector Laboratories).  The fluorescence labeled cells was examined by Elite Delta 
Vision microscope (GE) at 60X oil immersion lens. 
2.2.10. Determination of wild type and altered AQP1 half-lives from different 
transfectants 
Mid-log phase LdBob promastigotes were treated with 70 mg ml-1 cycloheximide 
and cells were harvested at different time points as described previously (Mandal et al., 
2012).  Flagella were isolated from cells collected at each time-point.  Levels of AQP1 
expression were analyzed as described above.  However, for AQP1WT + MPK2K42A a 
total flagellar protein of 70 µg was loaded in each lane.  Densitometric analyses of 
expression of AQP1 were performed from immunoblots using the ImageJ software 
(http://imagej.nih.gov/ij/).  The expression ratio was determined after normalizing AQP1 
band intensity at each time-point against that at zero hour. 
2.2.11. Determination of AQP1 mRNA levels from different transfectants 
Total RNA was isolated from each transfectant and AQP1 mRNA levels from 
different transfectants were determined by QPCR as described previously (Mandal et al., 
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2015).  2 µl of diluted purified cDNA reaction corresponding to 6 ng of template RNA, 
were used in a 10 µl reaction containing forward (5’-CTGTGTCTTTGGTGCCTTTCC-
3’) and reverse (5’-GCCTTTTGGGCGTCGTC-3’) primers for AQP1.  The relative 
abundance of target amplicons between samples was estimated using glyceraldehyde 3-
phosphate dehydrogenase (GAPDH) (forward primer 5’-
GGAGATAGACAAGGCCATCAAG-3’ and reverse primer 5’-
TGTCGTTGATGAAGTCAGAGC-3’) as loading control by the 2−ΔΔCT method (Livak 
and Schmittgen 2001).  Error bars were calculated from the mean ± SD of three 
independent experiments in triplicate.   
2.3. Results 
2.3.1. AQP1 degradation is mediated by the proteasome 
Previously, we showed that AQP1WT was highly destabilized in L. donovani 
promastigotes when it was overexpressed in the presence of MPK2K42A that was unable 
to complete the phosphoryl transfer to its substrate.  We asked whether this enhanced 
degradation below the steady state level is due to ubiquitination mediated leishmanial 
26S proteasomal degradation.  A wild type strain of L. donovani was chosen for the 
following reasons although the AQP1 knockout strain of L major recently became 
available from the Ouellette lab (in collaboration with the Mukhopadhyay lab) (Plourdea 
2015) :  (i) this study is a logical extension of our previous findings performed in L. 
donovani, (ii) We have recently shown that L. donovani has the lowest level of AQP1 
mRNA, is highly resistant to Sb(III)/(V) and shows the lowest accumulation of Sb(III).  It 
is also a very poor osmoregulator (Mandal et al., 2015).  These properties of the LdBOB 
   71
strain that we have used are almost as good as an AQP1 knockdown strain of Leishmania.  
L. donovani was chosen in the absence of an AQP1 knockout strain, as this species has 
the lowest level of AQP1 mRNA level, is highly resistant to Sb(III)/(V) and shows the 
lowest accumulation of Sb(III).  It is also a very poor osmoregulator (Mandal et al., 
2015).   L. donovani promastigotes overexpressing AQP1WT alone and AQP1WT + 
MPK2K42A were treated with 10 µM MG132, a global proteasome inhibitor, for 48 hr.  
We could not isolate flagella from these cells as they became circular with very short 
flagella because of metabolic stress (Figure 18).  
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Cell shape change due to MG132 has been observed before in mammalian cells 
(Ukekawa et al., 2004; Li et al., 2013).  A lower concentration (5 µM) of MG132, which 
was reported previously (Perez-Pertejo et al., 2011), also elicited a similar change in cell 
shape.  In addition, MG132 slowed down the growth of the promastigotes.  However, cell 
viability was not compromised.  Therefore, total membrane protein was isolated from 
these cells and AQP1 expression was observed by immunoblot.  Previously, work from 
the Mukhopadhyay lab observed that AQP1 was not detected in total plasma membranes 
isolated from the promastigotes even when overexpressing AQP1WT (Figarella et al., 
2007).  However, total plasma membrane isolated from promastigotes treated with 
MG132 showed expression of AQP1 even when the protein was completely destabilized 
in AQP1WT + MPK2K42A in the absence of MG132 (Figure 19A).  This shows the 
protective behavior of a proteasome inhibitor on AQP1.  The MG132 treated 
promastigotes were also hypersensitive to Sb(III) and accumulated more of the metalloid 
when compared to untreated cells (Figure 19B).  AQP1WT cells treated with MG132 were 
three times more sensitive to Sb(III) and accumulated twice as much of the drug when 
compared to cells grown in the absence of MG132 (Figure 19C).  AQP1WT + MPK2K42A 
cells became ten times more hypersensitive to Sb(III) (Figure 19B) and accumulated four 
times as much of the antimonial drug (Figure 19C) when compared to the untreated 
promastigotes. 
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2.3.2. Lysine 12 as the putative ubiquitination site of AQP1 
Proteasome mediated degradation and/or endocytosis of membrane proteins 
including aquaporins takes place by ubiquitination at critical lysines exposed to the 
cytosol (Kamsteeg et al., 2006; Moeller et al., 2011).  We analyzed the L. major AQP1 
sequence by predicting a topology of AQP1 and by Ub-Pred (Radivojac et al., 2010).  
Figure 20 shows that both N-and C-termini of AQP1 are cytosolic.   
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Figure 21 shows that lysine 12 (K12) is the only predicted ubiquitination site in AQP1 
(http:/www.ubpred.org).  K12 is also conserved across six major Leishmania species 
(Figure 22). 
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Additionally, the disordered cytosolic N-terminus is often involved in accelerated 
degradation of proteins by ubiquitination (Landre et al., 2013 ; Vittal et al., 2015).  We 
used RONN (Regional Order Neural Network) v3.2 (Yang et al., 2005) and PrDOS 
(protein disorder prediction system) (Ishida and Kinoshita 2007) to predict the disorder in 
AQP1 sequence; both software programs identified the cytosolic N-terminus where K12 
is located as the only reasonable disordered site of the protein (Figure 20 and Figure 23).   
 
 
 
L. braziliensis    1 --MDEDQQQRQKRDLTAQDTWPLYRYRWWIREYVAEFFGSFFLLSFGIGVTATTTFHAGN 
L. panamensis      1 --MDEDQQQRQKRDLTAQDTWPLYRYRWWIREYVAEFFGSFFLLSFGIGVTATTTFHAGN 
L. major           1 MHEEEEDQHESKRNFMSQNRWPLYRYRWRLREYVAEFFGTFFLVTFGTGVVATTVFHGGT 
L. tropica         1 MHEEEEGQLENKRNFTLQNRWPLYKYRWRIREYVAEFFGTFFLVTFGTGVIATTVFHAGN 
L. donovani        1 MHEEEQGQLEGKRNFTSQNRWPLYKYRWWLREYVAEFFGTFFLVTFGTGVIATTVFHAGN 
L. infantum        1 MHEEEQGQLEGKRNFTSQNRWPLYKYRWWLREYVAEFFGTFFLVTFGTGVIATTVFHAGN 
 
 
L. braziliensis   59 TASFQTNVSYLAITLGWGFGLAIALFITMGVSGGHLNPAVTLANCAFGAFPWRKAPGFML 
L. panamensis     59 TASFQTNVSYLAITLGWGFGLAIALFITMGVSGGHLNPAVTLANCAFGAFPWRKAPGFML 
L. major          61 TAMYQSNSSYLAITFGWAFGLAISLFLSMAVSGGHLNPAVTLANCVFGTFPWVKLPGYFL 
L. tropica        61 AASYQSNSSYLAITFGWGFGLTIGLFLSMAVSGGHLNPAVTLANCVFGTFPWIKLPGYFL 
L. donovani       61 AASYQSNSSYMAITFGWGFGLTIGLFLSMAVSGGHLNPAVTLANCVFGAFPWIKLPGYFL 
L. infantum       61 AASYQSNSSYMAITFGWGFGLTIGLFLSMAVSGGHLNPAVTLANCVFGAFPWIKLPGYFL 
 
 
L. braziliensis  119 AQLLGAILGAANVYGLFKQHFDDAGVMLLPNETMASKFSGVFVTYPNVSNVFAVWSEIFN 
L. panamensis    119 AQLLGAILGAANVYGLFKQHFDDAAVMLLPNETMASKFSGVFVTYPNVSNVFAVWSEIFN 
L. major         121 AQFLGGFVGAANTYVLFKSHFDEAEKRLLLNETMASKYGGIFATYPNVANTYAVWSEVFN 
L. tropica       121 AQFLGGFVGAANTYMLFKSHFDDAQKMLSPSETMASKYSGIFATYPNVANTYAVWSEVFN 
L. donovani      121 AQFLGGLVGAANTYGLFKSHFDDAQKALLPNETMASKYSGIFATYPNVANTYAVWSEVFN 
L. infantum      121 AQFLGGLVGAANTYGLFKSHFDDAQKALLPNETMASKYSGIFATYPNVANTYAVWSEVFN 
 
 
L. braziliensis  179 TMVLMMGILAINDNRMTPADGYKPVAVGLLLFVIGITTGINSGYALNPTRDLGPRIFTAM 
L. panamensis    179 TMVLMMGILAINDNRMTPADGYKPVAVGLLLFVIGITTGINSGYALNPTRDLGPRIFTAM 
L. major         181 TMALMMGILAITDARMTPAVDYKPVAIGLLLFVIGIASGINSSYGLNPARDLSPRILSAM 
L. tropica       181 TMALMMGILAITDPRMTPAVNYKPVAIGLLLFVIGITSGINSSYGLNPARDLSPRILSAI 
L. donovani      181 TMALMMGILAITDPRMTPAVNYKPVAIGLLLFVIGITSGINSSYGLNPARDLSPRILSAM 
L. infantum      181 TMALMMGILAITDPRMTPAVNYKPVAIGLLLFVIGITTGINSSYGLNPARDLSPRILSAM 
 
 
L. braziliensis  239 LWGKEPFTLHGYYFWIPIVGPIAGALLGMFLYVFCIIPSGA 
L. panamensis    239 LWGKEPFILHGYYFWIPIVGPIAGALLGMFLYVFCIIPSGA 
L. major         241 LWGSEPFTLHSYYFWIPLVVPFVGALFGMFLYVFFIIPPSC 
L. tropica       241 LWGSEPFTLYSHYFWIPLVAPFVGALLGMFLYVFFIIPPSC 
L. donovani      241 LWGSEPFTLYSYYFWIPLVAPFVGALLGMFLYVFFIIPPNF 
L. infantum      241 LWGSEPFTLYSYYFWIPLVAPFVGALLGMFLYVFFIIPPNF 
 
  Figure 22. Protein sequence alignment of Leishmania AQP1 from six different species  
K12 
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Therefore, we altered K12 of AQP1 to alanine (AQP1K12A) and arginine (AQP1K12R) by 
site directed mutagenesis and over expressed alone or in the presence of wild type MPK2 
or MPK2 K42A in L. donovani.   
 
 
 
   78
2.3.3. Alteration of lysine 12 of AQP1 confers efficient osmoregulation in Leishmania 
We have shown that the physiological function of AQP1 in Leishmania is 
osmoregulation.  The strategic flagellar localization of AQP1 helps the parasite sense the 
changing osmotic environments between the vector and the host (Figarella et al., 2007).  
The Mukhopadhyay Lab previously showed that osmoregulatory capacity of the 
promastigotes was directly proportional to the AQP1 protein levels in the membrane 
(Figarella et al., 2007; Mandal et al., 2012; Mandal et al., 2015).  Our work also 
demonstrated that when wild type AQP1 was co-expressed with MPK2K42A, the 
antimony facilitator was destabilized and showed poor osmoregulation when compared to 
AQP1WT or AQP1WT+MPK2WT cells (Mandal et al., 2012) (for details of all 
strains/transfectants see Table 1).  Cells expressing wild-type AQP1 exhibited a complete 
volume recovery in 56 s whereas the vector control needed 180 s (Figure 24 and Fig 25).  
Consistent with their slightly increased expression, cells expressing either AQP1K12A or 
AQP1K12R exhibited a complete volume recovery in 43 s and 30 s, respectively (Figure 24 
and Figure 25).  When cells coexpressing wild-type AQP1 and MPK2 were subjected to a 
similar hypo-osmotic shock, the swelling and recovery process was essentially complete 
within the dead time of the spectrophotometer (Figure 24 and Figure 25).  Cells 
coexpressing AQP1WT and MPK2K42A exhibited near negligible expression of AQP1 and 
took nearly 150 s for volume recovery (Figure 24 and 25).  In contrast, cells coexpressing 
AQP1K12A or AQP1K12R and either the wild type or altered MPK2 exhibited an identical 
volume recovery as cells transfected with wild type AQP1 and MPK2 (Figure 24 and 
Figure 25). Taken together, these results demonstrate that reduced AQP1 ubiquitination 
following alteration of Lys12 leads to increased protein stability and increased levels of 
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AQP1 expression (Figure 28), which provides improved osmoregulation in promastigotes 
(Figure 24 and Figure 25).  
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2.3.4. Alteration of lysine 12 of AQP1 confers antimonite sensitivity in Leishmania 
Difference in Sb(III) sensitivity among the strains described above was 
determined by exposing the promastigotes at increasing concentrations of potassium 
antimonyl tartrate.  AQP1WT+MPK2K42A cells were 80 times more resistant to Sb(III), 
whereas AQP1K12R and AQP1K12A cells were 1.5-2 times more sensitive to Sb(III) when 
compared to AQP1WT alone cells.  However, when lysine 12 was replaced with alanine or 
arginine in AQP1 and co-expressed with MPK2K42A, promastigotes became 
hypersensitive to Sb(III).  AQP1K12A+MPK2K42A and AQP1K12R+MPK2K42A cells were 
600 times and 400 times more sensitive to Sb(III) respectively when compared to 
AQP1WT+MPK2K42A cells (Table 2).  On the other hand, 
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AQP1K12A/AQP1K12R+MPK2WT cells showed a similar sensitivity profile when 
compared to AQP1WT+MPK2WT cells (Table 2).   
Table 2.  Antimonite accumulation and sensitivity of LdBob cells expressing AQP1 
and/or MPK2 
The Sb(III) accumulation in these various cell types were also examined.  
AQP1WT+MPK2K42A cells had the lowest accumulation of Sb(III), which was similar to 
vector alone control, whereas AQP1 alone cells had 3 times more intracellular antimonite 
levels (Table 2) .  AQP1K12A/AQP1K12R cells accumulated similar levels of Sb(III) when 
compared to promastigotes overexpressing wild type AQP1 alone.  However, 
AQP1K12A+MPK2K42A and AQP1K12R+MPK2K42A cells accumulated 6 and 5.5 times 
more Sb(III) when compared to AQP1WT+MPK2K42A cells.  On the other hand, 
AQP1K12A/AQP1K12R+MPK2WT cells showed a similar Sb(III) accumulation profile to 
AQP1WT+MPK2WT  cells (Table 2).    
Strain Sb(III) accumulation 
(nmol/109 cells) 
EC50 
[Sb(III)] μM 
Vector 2 ± 0.2 130 ± 5 
AQP1WT 9 ± 0.6 1 ± 0.01 
AQP1K12A 11 ± 0.4 0.7 ± 0.09 
AQP1K12R 12 ± 0.7 0.5 ± 0.02 
AQP1WT + MPK2WT 21 ± 0.4 0.1 ± 0.002 
AQP1WT + MPK2K42A 3 ± 0.3 80 ± 3 
AQP1K12A + MPK2WT 19 ± 0.7 0.1 ± 0.002 
AQP1K12A + MPK2K42A 21 ± 0.7 0.1 ± 0.002 
AQP1K12R + MPK2WT 19 ± 0.6 0.1 ± 0.002 
AQP1K12R + MPK2K42A 19 ± 0.9 0.1 ± 0.002 
MPK2WT 2 ± 0.2 105 ± 5 
MPK2K42A 2 ± 0.2 105 ± 5 
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2.3.5. Lysine 12 is responsible for MPK2K42A mediated degradation of AQP1 
We performed immunoblot analysis to determine whether the reversal of 
osmoregulatory capacity, the hypersensitivity to Sb(III), and the higher accumulation of 
Sb(III) of AQP1WT+MPK2K42A cells, when wild type AQP1 was exchanged with 
AQP1K12A/AQP1K12R, was due to altered expression of AQP1.  To examine the 
expression of AQP1, both flagellar and pellicular membrane fractions were isolated from 
the promastigotes of the various strains.  Immunoblot analysis of the flagellar fraction 
probed with anti-LmAQP1 antibody (Figarella et al., 2007) confirmed our previous 
observation that MPK2 stabilized AQP1 and redistributed to the pellicular membrane; 
however, the antimonite facilitator was destabilized in the presence of MPK2K42A (Figure 
26) (Mandal et al., 2012).  When the putative ubiquitination site K12 of AQP1 was 
replaced with alanine or arginine, the MPK2K42A mediated destabilization was reversed 
(Figure 26).  In fact, AQP1 expression in these strains restored to the levels of 
AQP1WT+MPK2WT cells, however, they were expressed exclusively in the flagellar 
membrane (Figure 26).  Promastigotes overexpressing AQP1K12A/AQP1K12R could be 
detected at slightly higher levels (P = 0.03 and P < 0.001, respectively) than wild type in 
the flagellar membrane indicating that alteration of lysine12 to either alanine or arginine 
increased AQP1 expression (Figure 26).  Additionally, when AQP1K12A/AQP1K12R was 
co-expressed with wild type MPK2, AQP1 did not show any change in expression when 
compared to AQP1WT+MPK2WT cells.  They did not redistribute to the pellicular 
membrane (Figure 26).  
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A polyclonal antibody (anti-LmxMPK2) against the synthetic peptide 
CGLESRPVEREAAVRK, corresponding to amino acids 444–458 of LmxMPK2 was 
used.  Anti-LmxMPK2 can detect MPK2 as well as L. donovani MPK2 (LdoMPK2) 
(Mandal et al. 2012).  Immunoblot analysis showed that MPK2 was expressed in 
promastigotes transfected with either MPK2 alone or co-transfected with AQP1 and 
MPK2.  Expression of endogenous LdoMPK2 was also detected in cells transfected with 
either AQP1 or altered AQP1 or in the vector control.  Cells expressing 
AQP1K12A/AQP1K12R co-transfected with MPK2 also showed a dense band similar to 
MPK2 (Figure 26). 
Immunofluorescence experiments also supported the immunoblot data.   As 
observed previously, AQP1 was detected in the flagellum of the promastigotes in AQP1 
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alone cells (Figure 27A) and showed a diffused localization in AQP1WT+MPK2WT cells 
(Figure 27B).  AQP1 expression in the flagellum was hardly detected in 
AQP1WT+MPK2K42A cells (Figure 27C), whereas AQP1K12A/AQP1K12R+MPK2K42A cells 
exhibited an exclusive flagellar localization similar to AQP1 cells (Figure 27F and I).  As 
expected, AQP1K12A/AQP1K12R alone (Figure 27 D and G) cells showed flagellar 
localization of AQP1.  Interestingly, when coexpressed with MPK2WT, altered AQP1 was 
observed on the flagellum only but not on the pellicular membrane of promastigotes 
(Figure 27E and H).  We interpret this observation as Lys12 being an essential element in 
the relocalization of AQP1 between different cellular compartments.  In contrast to 
coexpression of wild type AQP1 and MPK2K42A where AQP1 is hardly detectable (Figure 
27C), coexpression of altered AQP1with MPK2K42A showed the localization of 
AQP1K12A or AQP1K12R to flagellum alone (Figure 27F and I).  These observations again 
suggest that alteration of Lys12 prevents proteasome-mediated degradation.  
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2.3.6. Reversal of K42AMPK2 mediated destabilization of AQP1 by alteration of 
lysine 12 takes place by increasing its half life 
To determine whether removal of K12 stabilizes AQP1 in the presence of 
MPK2K42A by modification of its turnover rate, cycloheximide-blocking experiments 
were performed to measure protein half-lives.  Mid log phase promastigotes were treated 
with cycloheximide, followed by isolation of flagella at defined time intervals, and the 
decay of AQP1 was determined by SDS-PAGE and immunoblot analysis (Figure 28).  
AQP1 from AQP1WT+MPK2K42A cells was most unstable showing a half-life of only < 5 
h, whereas the Sb(III) facilitator from cells expressing AQP1 alone had a half-life of >60 
h (Figure 28).  AQP1K12A/AQP1K12R alone also had half-life similar to AQP1 alone.  As 
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observed before (Mandal et al., 2012), AQP1 from AQP1WT+MPK2WT cells were highly 
stable and showed only about 5% degradation during the whole experiment.  It was 
interesting to note that when this critical lysine was replaced with alanine, the MPK2K42A 
mediated degradation of AQP1 was stopped, and the half-life of the altered AQP1 was 
increased to the AQP1WT+MPK2WT levels.  Curiously, AQP1 from 
AQP1K12A/AQP1K12R+MPK2K42A cells showed a little instability up to 12 h (20-40%) but 
remained stable for the rest of the time period of the experiment.  These data clearly 
depict that removal of K12 at the N-terminus of AQP1 in the presence of MPK2K42A 
decreases the turnover number of AQP1. 
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2.4. Discussion 
  Aquaporin expression was stabilized from various cell types by proteasome 
inhibitors.  For example, osmotic stress decreased AQP4 expression in a retinal epithelial 
cell line which was reversed by proteasomal inhibitors (Willermain et al., 2014).  AQP1 
expression in mammalian fibroblasts was increased after treatment with the proteasomal 
inhibitor MG132 (Leitch et al., 2001).  AQP2 in mouse inner medullary collecting duct 
MCD3 cells was stabilized after treatment with MG132 (Umenishi et al., 2005).  
Therefore, ubiquitin-proteasome mediated degradation pathways of aquaporins have been 
described in various mammalian cell types, but not from kinetoplastids.  Proteasome 
mediated degradation of proteins requires ubiquitination at specific lysine residues.  
However, the existence of ubiquitin mediated post-translational regulation of parasite 
aquaporins especially in Leishmania is unknown.   
In this study, we show that Leishmania AQP1 was upregulated, and the 
promastigotes became hypersensitive when treated with a proteasomal inhibitor MG132 
(Figure 19B).  Accumulation of Sb(III) was also increased in MG132 treated cells (Figure 
19C).  We analyzed the AQP1 sequence using multiple software programs and identified 
K12 as the only putative ubiquitination site at the highly disordered N-terminus (Figure 
21).   Altering K12 to alanine/arginine of AQP1 and co-expressing it with MPK2K42A 
reversed its stability (Figure 26) by increasing its half-life (Figure 28).  Removal of this 
critical lysine from the disordered N-terminus of AQP1 also restored the antimonial 
sensitivity of the promastigotes because they accumulated more of the drug (Table 2).  
However, we have been unable to show a direct ubiquitination event at K12 by 
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immunoprecipitation experiments.  Pulling down ubiquitinated AQP1 either by anti-Ub 
or anti-AQP1 followed by an immunoblot failed because both of these polyclonal 
antibodies cross-reacted with each other in addition to their non-specific binding to other 
ubiquitinated proteins in the flagellar membrane.  In spite of the fact that the 
immunoprecipitation experiments failed, our data strongly suggest K12 as the putative 
ubiquitination site in AQP1 that accelerates its degradation in presence of MPK2K42A.  
 Earlier, we showed that AQP1, when phosphorylated in the presence of MPK2, 
was redistributed to the pellicular membrane along with the flagellar membrane (Mandal 
et al., 2012).  We interpreted that AQP1 was stabilized because of a conformational 
change due to phosphorylation at T197 and that it was enough for a relocalization signal.  
However, our current data, presented here, indicated that AQP1 did not redistribute to the 
pellicular membrane in the absence/presence of phosphorylation as soon as it stabilized in 
the absence of the putative ubiquitination site K12 (Figure 26 and 27).  AQP1 maintained 
its flagellar localization in AQP1K12A/AQP1K12R+MPK2WT or 
AQP1K12A/AQP1K12R+MPKK42A promastigotes, in spite of the fact that it was highly 
stabilized with a very low turnover number.  No changes in the mRNA levels of AQP1 
were observed in the strains where AQP1 was highly stabilized when compared to AQP1 
alone or AQP1WT+MPK2K42A cells (Table 3).   
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Table 3. AQP1 mRNA levels in various transfectants 
 
 Thus, it is reasonable to speculate that a lysine at this position of the N-terminus 
along with phosphorylation at T197 may be required to localize AQP1 to the flagellar 
membrane.  No specific signaling mechanisms for flagellar proteins have been 
established in kinetoplastids.  In this group of parasitic protozoans, a consensus sequence, 
HLA, is contained within two cytoskeletal flagellar proteins, paraflagellar rod A and 
trypanosome actin-related protein (Ersfeld and Gull 2001).  This sequence, however, is 
not universal.  For example the Leishmania enriettii glucose transporter ISO1 trafficks to 
the flagellar membrane, whereas ISO2 is routed to the pellicular membrane (Nasser and 
Landfear 2004).  However, AQP1 does not have any such sequences.  These are 
intriguing questions which will be addressed in a separate study very soon by combining 
our K12 and R13K mutants with T197 mutants of AQP1 and wild type/ MPK2K42A 
respectively. 
AQP1WT 1 
AQP1K12R 0.85 ± 0.28 
AQP1K12A 1.24 ± 0.12 
AQP1WT + MPK2WT 0.96 ± 0.22 
AQP1WT + MPK2K42A 1.14 ± 0.19 
AQP1K12A + MPK2WT 0.97 ± 0.08 
AQP1K12R + MPK2WT 1.05 ± 0.16 
AQP1K12A + MPK2K42A 1.17 ± 0.18 
AQP1K12R + MPK2K42A 1.03 ± 0.09  
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Based on the data obtained so far we propose a model to describe the mechanisms 
of AQP1 regulation at the post-translational level by probable ubiquitination and MPK2 
intervention (Figure 29).   
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When wild type AQP1 is present in the flagellar membrane in AQP1 alone cells, a 
steady state exists among synthesis, flagellar trafficking, recycling and degradation 
through proteasomal and/or endosomal-lysosomal pathways.  In AQP1K12A/AQP1K12R 
alone cells, this steady state may still be functional, as we observed somewhat increased 
stability of altered AQP1 more so than in AQP1K12R (Figure 26), most likely because 
AQP1 cannot get ubiquitinated at this point.  However, these cells may maintain the 
steady state by degrading AQP1 through ubiquitin-independent pathways, such as 
described for intrinsically disordered proteins (Erales and Coffino 2014; Sanchez-Lanzas 
and Castano 2014); as the N-terminus is still flip-floppy.  In AQP1WT+MPK2WT cells, 
MPK2 phosphorylates AQP1. As a result of this close association and structural changes 
in AQP1, the N-terminus assumes an ordered structure and also masks K12, leading to 
stabilization.   The recycling continues between the “on” (during phosphoryl transfer to 
AQP1) and “off” (release of AQP1 i.e. the substrate after phosphorylation is complete) 
phases of MPK2 association with AQP1.   
Now, let us consider the case of accelerated degradation of AQP1 in the presence 
of MPK2K42A (Figure 26).  It may be possible that the altered MPK2 docks onto AQP1 
and locks into an “on” position without the phosphorylation mediated transformation and 
release of AQP1.  This may expose K12 for ubiquitination again and may result in a 
hyper-flipping N-terminus, which leads to accelerated degradation through both 
proteasomal dependent and independent pathways.  The recycling and trafficking events 
are blocked because of constant “on” association of MPK2K42A with AQP1, and hence we 
observe a complete destabilization.  However, when K12 is removed from this equation, 
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ubiquitination mediated degradation does not take place.  Recycling and trafficking may 
also resume as MPK2K42A may be increasing order into that N-terminus in the absence of 
any ubiquitination.  It is also possible that other interacting partners of AQP1 are 
involved such as E3 ubiquitin ligases.  Experiments in support of this hypothesis and 
identification of additional partners of AQP1 should be completed in future.   
In the absence of any transcriptional control in Leishmania, such post-
translational regulation(s) of AQP1 provides the parasite a highly competent way to 
combat the osmotic challenges it faces during its life cycle and transmission.  It is 
tempting to speculate that upregulation of AQP1 by wild type MPK2 is a plus during a 
hypo-osmotic challenge right after transmission.  However, soon after, especially during 
a drug exposure, the parasite may use the intrinsically disordered N-terminus with the 
critical K12 at a strategic position to remove it from the membrane and downregulate 
AQP1 to become drug resistant. 
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CHAPTER 3 
ROLE OF 3’-UTR IN POST-TRANSCRIPTIONAL REGULATION OF AQP1 IN 
DIFFERENT SPECIES OF LEISHMANIA 
 
This study has been published: 
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Bhattacharjee, H., and Mukhopadhyay, R. Species-Specific Antimonial Sensitivity in 
Leishmania is driven by Post-Transcriptional Regulation of AQP1 (2015). PLoS 
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3.1 Introduction 
Leishmaniasis is caused by a digenetic parasite, which belongs to the genus 
Leishmania.  The disease affects almost 12 million people worldwide (Uzcategui et al., 
2008).  Female sandflies of the genus Phlebotomus and Lutzomyia are responsible for the 
transmission of the disease in the Old World and New World, respectively.  Life cycle of 
Leishmania include two morphologically distinct forms, namely, promastigote and 
amastigote.  Promastigotes are slender, spindle-shaped bodies with long anterior flagella 
that reside inside the gut of sandflies.  Once inside the vertebrate macrophages, 
promastigotes are transformed into amastigotes.  Amastigotes are small, oval-shaped, 
aflagelleted structures that reside inside the phagolysosomes of macrophages, proliferate 
by binary fission and finally burst out of infected cells and infect fresh macrophages, thus 
perpetuating the disease (Figarella et al., 2007).  Leishmaniasis ranges from self-healing 
cutaneous leishmaniasis (CL) to more debilitating and disfiguring mucocutaneous 
leishmaniasis (MCL) to fatal visceral leishmaniasis (VL).  Cutaneous leishmaniasis 
affects the skin by causing sores that usually occur at the site of the bite of the sandfly.  
Visceral leishmaniasis affects the visceral organs, primarily spleen, liver and bone 
marrow.  Mucocutaneous leishmaniasis affects the nasal and oral mucosal membrane.  
Localized CL caused by L. tropica and L. major usually affects areas of the face, neck 
and arms.  In diffuse Cutaneous leishmaniasis, which is caused by L. aethiopica and L 
.amazonensis (Mandal et al., 2014), the lesions formed on the body spread from one site 
to another.  The MCL infection, which is due to L. braziliensis, starts as Cutaneous 
leishmaniasis but some individual parasites spread into the mucous layer of the 
nasopharynx and cause mutilation of soft cartilage, leading to problems in the nose, 
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mouth and throat cavities (Mandal et al., 2014); MCL is fatal unless treated actively.  VL, 
also fatal if left untreated, is caused by L. donovani, L. infantum and L.chagasi.  The 
symptoms of VL include fever, hepatosplenomegaly, lymphoadenopathy and 
hyperglobulinemia.  At later stages, when hyperpigmentation of skin occurs, the levels of 
IgM and IgG increase and cell-mediated immunity decreases, which increases 
opportunities for multiple secondary infections. People suffering from HIV are more 
susceptible to VL (Mandal et al., 2010).  Pentavalent antimonite- Sodium stibogluconate 
(Pentostam) and Meglumine antimonite (Glucantime) are the first lines of treatment 
against all forms of leishmaniasis (Croft and Coombs 2003).  However, drug resistance 
remains a major barrier to effective treatment of all forms of leishmaniasis.  
Pentavalent antimony Sb(V) is the prodrug that gets reduced to Sb(III), which is 
the active form of the drug.  Reduction of Sb(V) metal may take place either in the 
parasite or in the macrophages or both.  Host macrophages play important roles in the 
reduction (Frezard et al., 2009).  Arsenic and antimony have similar properties and are 
transported via similar channels and pumps.  It was reported that one part of Sb(V) is 
reduced to Sb(III) by leishmanial As(V) reductase (Figure 30) or LmACR2 (Zhou et al., 
2006).  The resultant Sb(III) is conjugated to trypanothione (TSH) and is either exported 
out by an unknown efflux pump (Mukhopadhyay et al., 1996) and/or sequestered into 
small intracellular vesicles near the flagellar pocket of MRPA (Legare et al., 1997).  
These mechanisms seem to play substantial roles in Leishmania and also in field isolates.  
Haldar et al., 2011 reported that variability in the frequency of clinical antimonial 
resistance exists amongst Leishmania species.  However, it was not known yet whether 
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an intrinsic variation in antimonial sensitivity occurs among different Leishmania 
species.  Gourbal et al., 2004 reported that L. major was 50-70 times more sensitive to 
antimonite when compared to L. infantum.  It was also reported that Leishmania strains 
causing self-healing Cutaneous leishmaniasis have greater susceptibility towards 
oxidative stress as they have reduced thiol content (Sarkar et al., 2012).  However, a 
species-wide study has not been conducted, and the cause of this resistance remains 
unknown. 
 
 
To date, Leishmania aquaglyceroporin AQP1 is the only reported Sb(III) 
facilitator (Gourbal et al., 2004).  Disruption of one of the two AQP1 alleles in L. major 
resulted in a ten-fold increase in resistance to Sb(III) (Marquis et al., 2005).  This has 
been corroborated by downregulation of AQP1 mRNA levels in clinical isolates of drug 
resistant L. donovani.  On the other hand, overexpression of AQP1 makes the wild-type 
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parasites 100-fold more sensitive to Sb(III).  More importantly, overexpression of AQP1 
can abolish the drug resistance phenotype in drug resistant isolates (Gourbal et al., 2004) 
Taken together, AQP1 plays a significant role in the successful treatment of leishmaniasis 
using antimonials.  Other factors, such as levels of trypanothione and antimony-TSH 
conjugate exporter (Mukhopadhyay et al., 1996), also play  important roles in the 
generation of drug resistance. 
During our study with AQP1, we noticed that visceral species of Leishmania are 
much more antimonite (SbIII) resistant as compared to mucocutaneous and cutaneous 
species.  As we stated previously, AQP1 is the lone facilitator of Sb(III) in Leishmania, 
so we were curious to learn whether species-specific antimony resistance is driven by 
AQP1.  Trypanosomes, including Leishmania, do not have promoters, unlike other 
eukaryotes for RNA polymerase II, which is involved in the transcription of protein-
coding genes and is sensitive to α-amanitin.  Instead, these protein-coding genes are 
constitutively transcribed from large gene clusters, and steady state levels of their mature 
mRNAs are regulated post-transcriptionally by trans-splicing and polyadenylation 
(Kramer 2012 ; Haile and Papadopoulou 2007).  Several studies reported that post-
transcriptional regulation of developmentally expressed transcripts in Leishmania species 
involves sequences present mainly in the 3’-UTR (Muller et al., 2010 ; Boucher et al., 
2002; McNicoll et al., 2005; Bringaud et al., 2007), but also in the 5’UTR (Aly et al., 
1994; Lamontagne and Papadopoulou 1999) and in intergenic regions between tandemly 
repeated genes (Ramamoorthy et al., 1995; Beetham et al., 1997).  Logarithmic-stationary 
gene regulation is also regulated by 3’-UTR (Myung et al., 2002).    
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In this study, the 3’-UTRs of AQP1 were mapped and cloned from six different 
Leishmania species.  Each 3’-UTR fragment was approximately 1.8 kb in length, highly 
U-rich (30%) with only 49% GC (in a highly GC-rich genome), and contained several 
well-known instability elements described in higher eukaryotes.  Each3’-UTR fragment 
was very complex with several unique features: AU-rich (ARE) regions (highlighted in 
yellow), CU-rich (CURE) regions (highlighted in cyan), and Short Tandem Repeats 
(STRs, highlighted in green, Figure 31).   
  
Sometimes ARE and CURE sequences overlap. ARE regions are expected to 
destabilize mRNA (Winzen et al., 2007, Otkjaer et al., 2010), and U-rich UTRs make 
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transcripts unstable (Rodrigues et al., 2010).  It is interesting to note that the Lm3’-UTR 
has more AU-rich regions than the Ld3’-UTR, although the stretches of CU-rich regions 
are essentially the same.  Although the protein sequences of AQP1 among these six 
species are more than 80% homologous, their 3’-UTR differs significantly.   The 3’-
UTRs of AQP1 were mapped and cloned from six species: L. donovani (Ld3’-UTR), L. 
major (Lm3’-UTR), L. infantum (Li3’-UTR), L. tropica (Lt3’-UTR), L. braziliensis 
(Lb3’-UTR) and L. panamensis (Lp3’-UTR).  The rationale behind choosing different 
species was to represent every endemic continent (Asia [L. donovani, L. infantum, L. 
major and L. tropica], Africa [same as Asia], Europe [L. infantum, L. major and L. 
tropica] and America [L. infantum, L. braziliensis and L. panamensis)]); clinical 
manifestation (VL- L. donovani, L. infantum; Cutaneous leishmaniasis- rest of the 
species; MCL- L. braziliensis); and mode of transmission (anthroponotic- L. donovani 
and L. tropica; zoonotic- rest of the species) (Mandal et al., 2015).  This study shows that 
the species-specific antimonial resistance in Leishmania is uniquely driven by AQP1 and 
the post-transcriptional regulation is modulated by the respective unique 3’-UTR of each 
species-specific AQP1. 
3.2. Materials and methods 
3.2.1. Cell culture and infections 
  Leishmania donovani strain LdBob, L. infantum, L. major strain LV39 and L. 
braziliensis were kind gifts from Professor Stephen M. Beverley from Washington 
University School of Medicine; Professor Barbara Papadopoulou and Professor Marc 
Ouellette from Laval University, Quebec; and Professor Kwang-Poo Chang from 
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Rosalind Franklin University . L. tropica and L. panamensis were purchased from ATCC.  
Leishmania promastigotes were grown and maintained as described earlier in section 
2.2.1 (Figarella et al., 2007,Uzcategui et al., 2008) as well as maintained on blood agar 
slant brain heart infusion broth biphasic medium.  Blood agar slants were prepared using 
3.7% brain heart infusion (BHI), 1.7% agar and defibrinated rabbit blood. 
3.2.2. Antimony sensitivity assay 
  Antimony sensitivity assay of the promastigote was described previously in 
Section 2.2.4 (Chapter 2) (Sharma et al., 2015) 
3.2.3. Uptake assay 
The transport assay was performed using log phase (108cells/ml) promastigotes.  
Cells were washed twice with PBS, pH 7.4 (Thermo scientific) and resuspended in PBS.  
Promastigote cells were incubated with 10 mM potassium antimonyl tartarate [Sb(III)] 
for different time points at room temperature.  At each time point, 200µl of cells were 
filtered through a nitrocellulose membrane, and the filters were washed with 5ml of ice-
cold PBS.  The intracellular contents of antimony were determined as described 
previously (Gourbal et al., 2004). 
 Membrane vesicles were prepared from promastigotes of each species as 
described previously (Mukhopadhyay et al., 1996).  They were rapidly frozen in liquid 
nitrogen in small aliquots and stored at -80°C until use.  The total protein content of the 
plasma membrane fractions was determined by a filter assay as described previously 
(Schaffner and Weissmann 1973).  ATP-dependent uptake of Sb(TS)2 was measured 
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with 10 mM ATP as the energy source, as described previously, with a few changes 
(Mukhopadhyay et al., 1996).  Briefly, vesicles were added at 0.5 mg of membrane 
protein/ml and incubated with 0.1 mM of Sb(TS)2 in a buffer containing 75MM HEPES-
KOH, pH 7.0/0.15M KCl.  The reaction was started by the addition of ATP at room 
temperature.  At the indicated intervals, samples (0.1 ml) were removed and filtered on a 
wet 0.22 μm nitrocellulose filter, and the filter was washed once with 5 ml of ice-cold 
PBS.  The membranes were digested with 70% HNO3, and total Sb content was 
measured by ICP-MS as described above.  Each transport experiment was repeated at 
least two times with triplicate samples.  Error bars were calculated from the mean ± SE. 
3.2.4. Cell volume measurements 
Relative changes in cell volume were measured upon introduction of hypo-
osmotic stress. Please refer to section 2.2.6 (Chapter 2) for details (Sharma et al., 2015) 
3.2.5. Isolation of nucleic acids 
DNAzolTM reagent was used for isolation of genomic DNA. Total RNA from 
Leishmania promastigote cells was isolated using TRIZOL reagent, according to the 
manufacturer’s protocol. DNA was removed from total RNA preparation using TURBO 
DNA-free™ Kit (Ambion), according to the manufacturer’s instructions (Müller et al., 
2010).  The integrity of total RNA preparations was confirmed by denaturing agarose 
gel electrophoresis. 
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3.2.6. Mapping of 3’-UTR 
The 3’-UTR fragment for each of the six Leishmania species was mapped using 
3’RACE kit (Invitrogen) with 2 µg of total RNA input and gene-specific primers, 
according to the manufacturer’s protocol.  The gene-specific primers were designed 
according to genome sequences in http://tritrypdb.org/tritrypdb. The amplified 3’-UTR 
fragments for all the species were cloned into pGEMT-Easy vector (Promega), according 
to the manufacturer’s instructions, and sequenced (Eton Biosciences) (Mandal et al., 
2015). 
3.2.7. Plasmid construction and transfection 
The luciferase (LUC) expression vector for Leishmania pSPYNEOαLUC was 
described previously (Boucher et al., 2002) and is referred to as LUC-control in this 
study.  The full-length 3’-UTR of AQP1 and 200 bp beyond the 3’ end of the poly (A) 
site was PCR amplified from the genomic DNA of each species using AccuPrime™ Taq 
DNA Polymerase (Invitrogen) and primers with inserted BamHI or SalI restriction sites.   
The PCR products were cloned into the pGEMT-Easy vector (Promega) and sequenced 
(Eton Bioscience).  The different LUC-chimeric constructs were generated by digesting 
the pGEMT-Easy clones with BamHI or SalI (New England Biolab) and subcloned into 
the BamHI or SalI site 3’ to the LUC gene in the vector pSPYNEOαLUC, respectively.  
All plasmid constructs were purified using QIAprep Spin Miniprep Kit (Qiagen).  
Purified plasmid constructs were transfected into Leishmania by electroporation.  Briefly, 
stationary phase promastigotes were washed and resuspended in an ice-cold 
electroporation buffer (21 mM HEPES, 150 µM NaCl, 5 mM MgCl2, 120 mM KCl, 0.7 
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mM NaH2PO4, 6 mM glucose) at a density of 108cells/ml. Three hundred microliters of 
resuspended cells were transferred to 0.2 cm electroporation cuvette (Bio-rad) with 13 µg 
of plasmid DNA.  Cells were electroporated in Gene Pulser (Bio-rad) at 0.45 kV and 500 
µF.  All transfectants were selected and maintained in the presence of 60 µg/ml genticin 
(G418) (Invitrogen). 
3.2.8. qPCR and qRT-PCR analyses 
  cDNA synthesis was carried out using 500 ng of total RNA and AccuScript High 
Fidelity 1st strand cDNA synthesis kit (Agilent), according to the manufacturer’s 
instructions. The first-strand cDNA reaction mix was treated with 0.25N NaOH at 65°C 
for 30 min to degrade the input RNA molecules. The reaction mix was then neutralized 
using HCl and purified using Qiagen PCR purification kit, according to the 
manufacturer’s instructions. For qPCR, 4 µg of genomic DNA, and for qRT-PCR, 2 µl of 
diluted, purified cDNA reaction corresponding to 6 ng of input RNA, was used in a 10 µl 
reaction containing forward and reverse primers for the target genes and 1X iQTMSYBR 
Green supermix (Bio-rad). The reactions were run on an Eppendorf Realplex2 PCR 
machine in the following thermal cycling conditions: initial denaturation at 95°C for 3 
min followed by 40 cycles of 95°C for 15 sec and 65°C for 20 sec. A final melting curve 
analysis was performed for each reaction to confirm that the PCR generated a single 
amplification product. The relative abundance of target amplicons between samples were 
estimated using the 2−ΔΔCT method (Mary et al., 2010). Error bars were calculated from 
the mean ± SE of three independent experiments in triplicate. 
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3.2.9. RNA stability assays 
  To determine the half-lives of AQP1, mid-log phase promastigotes were treated 
with sinefungin (5 µM) for 15 min, followed by incubation with 10 µg/ml of actinomycin 
D (Sigma) to arrest trans-splicing and transcription. Cells were harvested at various time 
points.  Total RNA isolation and qRT-PCR analyses were performed as described earlier. 
Error bars were calculated from the mean ± SE of three independent experiments in 
triplicate (Boucher et al., 2002). 
3.2.10. Luciferase activity assay 
  Mid-log phase promastigotes (5x106) were lysed with 50 µl of lysis buffer (62.5 
mM Tris-phosphate pH 7.8, 5 mM DTT, 2.5% Triton X-100, 25% glycerol).  A 10 µl of 
lysate was used to estimate the luciferase activity using Luc-Screen® Extended-Glow 
Luciferase Reporter Gene Assay System (Life Technologies) according to the 
manufacturer’s instructions.  The luciferase activities were normalized against the 
relative copy number of the plasmid constructs in each transfectant.  Error bars were 
calculated from the mean ± SE of three independent experiments in triplicate (Mandal et 
al., 2015). 
3.2.11. Western blot analysis 
Whole cell lysates were prepared by lysing 1x108 promastigotes from each 
transfectant in 100 µl 1x Laemmli’s buffer.  A 10 µl of lysate was used to fractionate 
proteins on 12% SDS-PAGE.  Fractionated proteins were electroblotted on nitrocellulose 
membranes.  The amounts of luciferase and neomycin phosphotransferase proteins were 
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estimated using goat anti-luciferase pAp (Promega) and rabbit anti-neomycin 
phosphotransferase antibody, respectively, followed by densitometric estimation (Mandal 
et al., 2015). .  
3. 3. Results 
3.3.1. Intrinsic species-specific antimonial resistance in Leishmania 
Intrinsic Sb(III) resistance in the representative six selected species was 
determined by exposing the promastigotes to increasing concentrations of potassium 
antimonyl tartrate. L. infantum was the most resistant species.  The EC50 data showed 
that it was 1.4 times more resistant when compared to L. donovani and 46, 15, 20 and 7 
times more resistant than the cutaneous species namely, L. major, L. tropica, L. 
braziliensis and L. panamensis, respectively (Table 4).  However, the cutaneous species 
also differed in sensitivity to Sb(III) among themselves.  L. tropica, L. braziliensis and L. 
panamensis are 3, 2.3 and 6 times, respectively, more resistant to Sb(III) when compared 
to L. major (Table 4).   
Table 4. Antimonite sensitivity of different species of Leishmania 
Species EC50 
Sb(III) μM 
L.braziliensis 10 + 2 
L.donovani 144 + 5 
L.infantum 199 + 22 
L.major 4.3 + 0.3 
L.panamensis 27 + 4 
L.tropica 13 + 1 
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3.3.2. Cutaneous leishmaniasis species accumulate more Sb(III) than the VL species  
In order to understand differential intrinsic antimonial sensitivity among different 
species, we examined the time-dependent intracellular accumulation of Sb(III) in 
promastigotes.  We observed that L. braziliensis showed the fastest and highest 
accumulation of Sb(III) at any given time followed by L. major, L. panamensis and L. 
tropica, whereas L. donovani and L. infantum showed the slowest rates and total 
accumulation of Sb(III) (Figure 32).   
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Therefore, our studies indicated that the antimony sensitive Cutaneous 
leishmaniasis species accumulated more total antimony when compared to the VL 
species.  Our next question was whether the accumulation signified lower uptake or 
increased efflux in the VL species and higher uptake or slower efflux in the Cutaneous 
leishmaniasis species.  To address this question, everted membrane vesicles were 
prepared from promastigotes of each species, and Sb-[TS]2 conjugate accumulation was 
measured in the presence of 10mM ATP as an energy source.  The rate of transport of Sb-
[TS]2  conjugate in the everted membrane vesicles of the six different species was not 
significantly different from each other, which indicated that differential sensitivity among 
different species was not due to a change in the efflux rate of antimony (Figure 33). 
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3.3.3. Osmoregulatory capacity of promastigotes is species-specific 
 Mukhopadhyay’s lab has previously shown that the physiological function of 
AQP1 in Leishmania is osmoregulation.  AQP1’s strategic localization in the flagella 
helped the parasite to sense the changing osmotic environment between the vector and 
the host (Figarella et al., 2007).  In wild type Leishmania, it was very difficult to detect 
AQP1 expression at the protein level with an antipeptide polyclonal anti-AQP1 antibody 
(Figarella et al., 2007).  Therefore, it is important to understand the significance of AQP1 
in all six species by determining their osmoregulatory capacities under hypo-osmotic 
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shock (50% reduction in osmolarity).  It was previously reported that osmoregulatory 
capacity is directly proportional to the AQP1 protein levels (Figarella et al., 2007, 
Mandal et al., 2012) in the membrane.  We observed that the Cutaneous leishmaniasis 
species osmoregulates much more efficiently when compared to the VL species as 
predicted by their EC50.  Studies show that VL species promastigotes with less AQP1 
mRNA are more resistant to antimonials when compared to Cutaneous leishmaniasis 
species promastigotes with more AQP1 mRNA.  We observed that L. donovani and L. 
infantum promastigotes swelled more rapidly (decrease in absorbance) and recovered 
their volume (increase in absorbance) more slowly when compared to all the Cutaneous 
leishmaniasis species (Figure 34).  Mandal et al., 2015 reported that L. braziliensis and L. 
panamensis showed the highest levels of AQP1 mRNA and that they were the most 
efficient osmoregulators, whereas L. infantum, with less AQP1 mRNA  compared to L. 
donovani, responds to hypo-osmotic shock less efficiently.  
3.3.4. AQP1 mRNA is more stable in the Cutaneous leishmaniasis species 
 Leishmania does not have any transcriptional control.  Thus, we examined the 
stability of AQP1 mRNA in all six species to determine if any post-transcriptional 
regulation is active in lowering the mRNA levels in the VL species.  In order to 
determine the turnover rate of AQP1 mRNA, mid log phase promastigotes of all species 
were treated with sinefungin (to stop pre-mRNA processing) (Mayer et al., 2012), 
followed by actinomycin D (inhibition of transcription) (Mishra et al., 2003), and then  
harvested up to 130 min.   We used quantitative PCR (qPCR) to determine the decay of 
AQP1 mRNA and normalized against the 0 minute (time of addition of actinomycin D).  
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The half-lives of the AQP1 mRNA in VL species, i.e. L donovani and L. infantum, were 
found to be 40 min and 26 min, respectively, whereas the half-lives of the Cutaneous 
leishmaniasis species, such as L. tropica and L. panamensis, were 57 and 117 min, 
respectively.  The half-lives of the AQP1 mRNA in L. braziliensis and L. major were 
estimated to be > 130min (Figure 35).  Therefore, AQP1 mRNA in the Cutaneous 
leishmaniasis species was much more stable than the VL species.  
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3.3.5. Cloning of 3’-UTRs of AQP1 mRNA from different species 
In order to obtain a detailed insight into mRNA stability in all six different species 
of Leishmania, we cloned individual 3’-UTRs of AQP1 mRNA from the Cutaneous 
leishmaniasis and VL species described in this study (Mandal et al., 2015).   Using the 3’-
RACE PCR technique, it was found that the length of the 3’-UTR of the AQP1 mRNA in 
each of the six species was approximately 1.8 kb in length.  When we compared the 
protein alignment sequences of AQP1 for all the species in ClustalW, we observed an 
overall similarity of 88%.  Also, the overall identity was 66% between the open reading 
frames (ORF) of AQP1 in all six species.  However, the sequences of the 3’-UTR from 
each of the six species were found to be more divergent and showed an overall identity of 
only 24%.  We found greater similarities between the pairs, for example, 99% identity 
between L. donovani and L. infantum (VL) 3’-UTR, 78% identity between L. major and 
L. tropica and 94% identity between L. braziliensis and L. panamensis.  
3.3.6. Role of the 3’-UTR in species-specific stability of AQP1 mRNA 
 Because 3’-UTR sequences are divergent between VL and Cutaneous 
leishmaniasis species, we hypothesized that these sequences are responsible for the 
species-specific differential AQP1 mRNA stability.  In order to understand the principal 
mechanism, we made a series of chimeric constructs with the full length 3’-UTR (~ 1.8 
kb) of the AQP1 mRNA from each of the six species by cloning them at the 3’ end of the 
luciferase (LUC) reporter gene (Figure 36).  
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These cassettes were flanked by an upstream α-tubulin intergenic (IR) region and 
by a downstream IR region (~ 200 bp) of each species-specific 3’-UTR of AQP1 mRNA 
to maintain the 5’ and 3’ processing of the LUC chimeric transcripts accurately.  Trans-
splicing signals, which are located 100-400 nt downstream of the polyadenylation site, 
often direct polyadenylation in trypanosomes (LeBowitz et al., 1993; Matthews et al., 
1994; Boucher et al., 2002).  These chimeras were expressed from an episomal plasmid 
pSPYNEOαLUC with neomycin phosphotransferase (NEO) as a marker.  In the current 
study, pLUC referred to the vector alone, where LUC expression was only regulated by 
the IR region of α-tubulin.  Each of the species-specific LUC-AQP1-3’-UTR constructs 
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were named pLUC-Ld (L. donovani), pLUC-Li (L. infantum), pLUC-Lm (L. major), 
pLUC-Lt (L. tropica), pLUC-Lb (L. braziliensis), and pLUC-Lp (L. panamensis).  Six 
individual chimeric constructs and the vector alone were transfected into the six species 
generating 42 transfectants (Mandal et al., 2015).  However, our discussion will be 
limited to the role of six 3’-UTRs in regulating LUC protein levels and LUC activity in a 
species-specific manner in L. donovani and L. major, as both species have remarkable 
differences in their 3’-UTR AQP1 sequences.  We will also address the mRNA steady 
state levels and stability in order to explain the role of all six 3’-UTRs in all six species.   
After L. donovani was transfected with each of the six different chimeric constructs and 
vector alone, we carried out western blot studies with an anti-luciferase antibody and 
completed densitometric analyses using α-tubulin as a loading control.  We observed that 
luciferase expression was lowest in pLUC-Li transfectants, at only about 21%, which 
resulted in about 18% luciferase activity when compared to pLUC control (Figure 37 and 
38).  pLUC-Ld, pLUC-Lm, pLUC-Lt, pLUC-Lb and pLUC-Lp transfectants expressed 
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1.5, 4.5, 2.6, 5.5, and 4.7 times more luciferase, respectively, when compared to pLUC-Li 
(Figure 38).  Similarly, when all the constructs were transfected in L. major, LUC 
expressions were similar in all of the Cutaneous leishmaniasis UTR constructs (Figure 
37). Further, 77% and 93% of LUC was expressed by pLUC-Li and pLUC-Ld 
transfectants, respectively, when compared to pLUC controls.  The highest LUC activity 
was observed in cells expressing LUC from pLUC-Lm, followed by pLUC-Lp, pLUC-Lt 
and pLUC-Lb (Figure 38).  
 
3.4. Discussion 
There is no single effective treatment available for all forms of leishmaniasis 
(Gonzalez et al., 2009).  Based on geographical location and the species responsible for 
infection, options for treatment are limited (Croft and Coombs 2003). The first line of 
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treatment against all forms of leishmaniasis is an antimonial drug, but treatment failure is 
a major problem. Treatment of American cutaneous leishmaniasis (ACL) is very complex 
and challenging.   Most commonly, intrinsic and acquired variations in the sensitivity of 
different Leishmania species are the factors, which influence the efficacy of drugs. 
Pentavalent antimonials are the most prescribed form of drugs for the treatment of ACL 
and MCL.  As per World Health Organization (WHO) standards, the recommended dose 
of pentavalent antimonial for the treatment of ACL is 20 mg/kg/day for 28 days 
(Reithinger et al., 2007).  Local physicians in the respective geographical location 
determine appropriate antimonial drug dosage based on experience and cannot be 
standardized (Tuon et al., 2008).  It is clinically proven that antimonial resistance prevails 
not only amongst different Leishmania species but it is also strain specific.  All these 
factors create a major impediment in implementing a single dose strategy for all forms of 
leishmaniasis.  Decuypere et al., 2012 reported that, under antimonial treatment pressure, 
molecular and phenotypic heterogeneities emerged in an L. donovani population of 
patients from Nepal.  Several studies reported that each genetically diverse population 
could acquire an antimonial resistant phenotype with a different molecular basis.  
Nevertheless, not a single mechanism in L. donovani was identified.  On the other hand, 
cutaneous leishmaniasis species have greater susceptibility towards oxidative stress 
because the production of non-protein thiols is much less when compared to the visceral 
leishmaniasis species from the Indian subcontinent (Sarkar et al., 2012).  Mandal et al., 
2015 reported that the non-protein thiol levels were similar in all VL and Cutaneous 
leishmaniasis species.  Our study aimed to address the controversial issue of species-
specific antimonial sensitivity in Leishmania.  We examined all commonly used drug 
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resistant markers ((i)MRPA (Legare et al., 2001); (ii) thiols (Mukhopadhyay et al., 1996; 
Mittal et al., 2007); (iii) an unknown efflux system (Dey et al., 1994; Dey et al., 1996); 
and (iv) AQP1 (Decuypere et al., 2005; Marquis et al., 2005; Maharjan et al., 2008) and 
determined whether there were any direct correlations among four Old World Leishmania 
species (L. donovani, L. infantum,  L. tropica and L. major) and two New world species 
(L. panamenisis and L. braziliensis). 
 Among the four most commonly used antimonial resistance makers, our 
discussion is focused on two factors, an efflux system and AQP1, in each of the six 
species.  MRPA and total non-protein thiol levels were addressed by Dr. Mandal, who 
observed that the MRPA mRNA levels were much higher in Cutaneous leishmaniasis 
species as compared to VL species.  In his studies, the total non-protein thiol levels were 
similar in both the Cutaneous leishmaniasis and VL species.  The Sb-[TS]2 efflux pump 
rate was similar in all six species, whereas downregulation of AQP1 seemed to be driving 
the species-specific antimonial sensitivity.  The two visceral species showed lower AQP1 
mRNA levels, less Sb(III) accumulation and less osmoregulatory capacity when 
compared to cutaneous species (Mandal et al., 2015).  
 In this study, we proved that the species-specific antimonial sensitivity in 
Leishmania is being driven by the regulation of AQP1 at the mRNA level.  We also 
showed that AQP1 mRNA is more stable in Cutaneous leishmaniasis species as 
compared to VL species.  Since, Leishmania does not have any transcriptional control, 
role of AQP1 3’-UTRs in the species-specific stabilization of AQP1 mRNA was 
determined by using the luciferase reporter assay.  Mandal et al., 2015 reported that, 
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under the control of VL 3’-UTR, LUC mRNA accumulation was found to be less in both 
VL and Cutaneous leishmaniasis species.  This proposes that there are no species-specific 
factors responsible for the regulation at the level of AQP1 mRNA stability.  However,  a 
difference in 3’-UTR sequences makes the trans-acting factor (s) more favorable to 
binding and to stabilizing or destabilizing the AQP1 mRNA, but there is no difference 
between the expression levels of 3’-UTRs of Cutaneous leishmaniasis species in VL and 
Cutaneous leishmaniasis species.  This suggests that there is no effect from any species-
specific trans-acting factor.  Mandal et al., 2015 reported that all 3’-UTRs of AQP1 
provided LUC mRNA with the highest level of stability in L. major.  
 It has been thoroughly investigated that multiple factors are responsible for 
mRNA stability in higher eukaryotes and mammalian cells.  Perhaps the best 
characterized family of instability determinants is the A+U rich elements (ARE) in the 
3’-UTR, which are known to regulate a variety of transcripts via mRNA degradation 
and/or translational repression (Knapinska et al., 2011).  Some known AUBPs (A + U 
binding proteins) are AUF1/hnRNP (heterogeneous nuclear ribonucleoprotein), TTP, 
BRF1 (Butyrate response factor), KSRP (KH-type splicing regulatory protein), TIA-1 (T-
cell internal antigen 1), and TIAR (TIA-1 related protein) (Barreau et al., 2005).   In 
trypanosomatids, RNA-binding proteins (RBP) are key factors in regulating gene 
expression. Over one hundred RBPs have been predicted to exist in trypanosomes, based 
on the presence of canonical RNA-binding domains:  RNA recognition motif (RRM), 
CCCH zinc fingers, and Pumilio or PUF domains.  Most of the characterized RBPs 
control mRNA abundance by stabilizing the target transcript.  In trypanosomatids, 
although indirect results suggest that some proteins cause degradation of target 
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transcripts, this has never been shown directly (Erben et al., 2014).   Since AQP1 mRNA 
in the VL species is more unstable compared to the Cutaneous leishmaniasis species, and 
this phenomenon is driven by their respective 3’-UTRs, we analyzed the predicted 3’-
UTR RNA structures of the most resistant (L. infantum) and the most sensitive (L. 
major), using RNA structure folding programs such as RNA fold and REPFIND.  We 
found two major AU-rich regions in L. infantum 3’-UTR sequence, whereas L. major had 
only one (Figure 39A and B).   
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 Secondary structure analyses showed that both of these regions are present in 
single-stranded loops in two out of three predictions (Figure 40) in L. infantum, while in 
L. major, they are in hairpins in all three predictions (Figure 40).   It has been observed 
that destabilizing elements preferably bind to ARE regions when they are present in loop 
structures (Meisner et al., 2004).  Also, CA repeats in the 3’-UTR have been reported to 
mediate constitutive decay, as is the case of bcl2 mRNA (Lee et al., 2004).  There are 
multiple CA repeats present in the AQP1 3’ UTRs of all species with the longest being 
in L. infantum (Figure 39).  Therefore, it is intriguing to speculate that these VL specific 
motifs may play a role in the instability of the AQP1 mRNA.  However, there may be 
other specific regions that are involved and yet not so evident from the primary 
sequences.  Therefore, a systematic study of the 3’-UTRs and trans-acting factors is 
necessary, which is currently in progress.  
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 The most intriguing question is why there is a species-specific regulation of 
AQP1 in Leishmania.  Antimonial resistance in Leishmania can be the result of a variety 
of factors.  It can be speculated that VL species show a higher antimonial resistance due 
to having a higher intrinsic mRNA instability, which in turn leads to a lower production 
of AQP1 (Haldar et al., 2011).  Conversely, the Cutaneous leishmaniasis species may be 
more efficient osmoregulators because it faces greater osmotic challenges during vector 
to host transmission, and more AQP1 may help them to overcome the barrier.  AQPs 
sometimes play an important role in other physiological processes and functions, such as 
lipid metabolism, epidermal biology, cell adhesion and, neural signal transduction 
(Mukhopadhyay et al., 2014).  So, it is very interesting to speculate that species-specific 
AQP1 expression may help the respective species to find their appropriate niches, 
resulting in tissue tropism.  In the cases of VL and Cutaneous leishmaniasis treatments, 
the amount of prescribed medication is similar and standardized by WHO.  So, it is quite 
possible that the lower dosage of antimonials for Kala-azar may have been the reason for 
the more prevalent drug resistance phenotype in the VL species of the field.  These are 
ambitious and yet intriguing and fundamental questions in Leishmania biology, which 
will be advanced by our novel finding of 3’-UTR driven species-specific regulation of 
AQP1.  
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Water is the chief component of all living cells.  Regulation of water homeostasis 
is indispensable for many biological processes.  A persistent question for many years was 
how water passed through biological membranes.  It was Peter Agre and his co-workers, 
in 1992 that identified the first mammalian water-selective channel in erythrocytes 
known as aquaporins or AQPs.  Significant advances have been made with regard to 
mammalian AQPs.  Mammalian AQPs are known to be involved in several diseases such 
as congenital cataracts, diabetes insipidus (NDI), brain edema, obesity, liver steatosis and 
type II diabetes mellitus (Gena et al., 2011).  In several studies, AQPs are the potential 
drug targets for drug synthesis or genetic engineering strategies to cure and/or prevent 
human diseases (Gena et al., 2011).  However, knowledge about parasite AQPs is lagging 
far behind.  Parasite AQPs are essential for the successful prolongation of the diseases 
caused by them.  Exploration of regulatory mechanisms of parasite AQPs will reveal their 
potential for novel chemotherapeutic approaches and/or transmission intervention(s) 
(Mandal et al., 2014).  As discussed in chapter I, aquaporins belong to the Major Intrinsic 
Proteins (MIP) superfamily, and depending on the substrate specificity, aquaporins can 
be divided into groups: “Aquaporins”, which facilitate the movement of water only, and 
“aquaglyceroporins”, which facilitate the movement of water along with glycerol and 
other small uncharged solutes. 
Aquaglyceroporins are instrumental in the transport of metalloids.  Metalloids, 
such as arsenic and antimony, are the intermediate elements which have properties of 
both metals and non-metals.  Arsenic and antimony cause toxicity, but also have 
chemotherapeutic values in treating medical conditions such as acute promyelocytic 
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leukemia (Beitz 2006) and several protozoan diseases.  Aquaglyceroporins facilitate the 
uptake of Arsenic(As) and Antimony(Sb), metalloids that can exist in pentavalent and 
trivalent oxidation state (Mukhopadhyay and Beitz 2010).  At neutral pH, the trivalent 
forms of these metalloids assume a molecular structure similar to glycerol; hence, they 
enter inside the cells through AQPs.  In E.coli, GlpF acts as a major route of As (III) 
entry (Bhattacharjee et al., 2008; Rosen and Tamás 2010).  Similarly, hAQP9 and plant 
NIPs are able to conduct metalloids across the membrane (Bhattacharjee et al., 2008).  In 
Saccharomyces cerevisiae, Fps1p aquaglyceroporin acts as As(III) transporter (Figure 41) 
(Liu et al., 2002).  
                           
As discussed in Chapter I, pentavalent antimonials [Sb(V)] are the primary drugs 
of choice against all forms of leishmaniasis (Gourbal et al., 2004).  Sb(V), a prodrug, is 
reduced to  trivalent antimony [Sb(III)], which is the active form of the drug.  Sadly, 
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several cases of leishmaniasis are becoming unresponsive to antimonials.  Options for 
second line of treatments are very limited and/or expensive and/or more toxic.  Thus, to 
modulate the drug unresponsiveness, there is a dire need for increased understanding of 
the antimony resistance mechanisms in Leishmania.  Antimony resistance in Leishmania 
is multifactorial (Mandal et al., 2015).  One of the important mechanisms is down 
regulation of the Sb(III) facilitator.  Our research group was the first to demonstrate the 
existence of a Sb(III) facilitator in Leishmania, namely, aquaglyceroporin 1  (AQP1).  
AQP1 is an adventitious facilitator of Sb(III) and to date the only reported facilitator of 
Sb(III) in Leishmania.  In Leishmania, AQP1 is involved in several important 
physiological functions, including osmoregulation and osmotaxis (Figarella et al., 2007). 
Efficient osmoregulation and osmotaxis are necessary for Leishmania, as the parasites 
face diverse osmotic challenges during the life cycle.  Hence, AQP1 is essential for the 
survival of promastigotes.  To conquer these challenges, Leishmania needs to regulate 
AQP1 efficiently.  Taken together, delineation of the AQP1 regulatory network could 
provide the tools for better management of this deadly pathogen.  Accordingly, the 
primary objective of my dissertation research was to understand the regulatory 
mechanism of AQP1 in Leishmania.  Expression of AQP1 in Leishmania is highly 
regulated.  It is known that, in the absence of definitive promoters, Leishmania primarily 
regulates its genes at post-transcriptional and/or post-translational levels.  We reported 
that mitogen activated protein kinase 2 (MPK2) positively regulated AQP1 stability 
through phosphorylation of the Thr197 residue (Mandal et al., 2012).  AQP1 
phosphorylated at Thr197 showed more stability whereas the absence of phosphorylation 
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makes AQP1 more susceptible to degradation.  It was also observed that in the presence 
of a variant MPK2 (MPKK42A) AQP1 was subjected to accelerated destabilization. 
Based on these studies, I investigated the role of ubiquitin mediated post-
translational regulation of Leishmania AQP1- an unknown mechanism for AQPs in 
protozoan parasites.  I analyzed the sequence of AQP1 using UbPred and RONN, and 
identified K12 as the single putative ubiquitination site at the disordered N-terminus.   
When I treated the promastigotes with proteasomal inhibitor MG132, the cells became 
hypersensitive to MG132, and AQP1 was upregulated.  When total membrane protein 
was isolated from MG132 treated cells, AQP1 expression was observed by immunoblot 
(Figure 19A) whereas the untreated cells did not show any expression of AQP1.  When I 
altered K12 to alanine/arginine of AQP1 and co-expressed it with MPK2K42A, the protein 
showed stability by increasing their half-lives (Figure 28).  Removal of the critical lysine 
also led to an increase in antimonial sensitivity of the promastigotes because the strains 
accumulated more of the drug (Table 3).  Previously, we reported that when co-expressed 
with MPK2, AQP1 was redistributed to the pellicular membrane along with the flagellar 
membrane but AQP1 maintained its flagellar localization in 
AQP1K12A/AQP1K12R+MPK2WT or AQP1K12A/AQP1K12R+MPKK42A promastigotes, in 
spite of the fact that AQP1 was highly stabilized with a very low turnover number.  
Based on the data, I proposed a model to describe a mechanism of AQP1 regulation at the 
post-translational level by probable ubiquitination2 and interaction with MPK2 at the 
disordered N-terminus of AQP1 (Figure 29).  Results of this study proved that MPK2K42A 
mediated accelerated destabilization of AQP1 was due to the presence of a critical lysine 
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12 (K12) at the disordered cytosolic N-terminus of the protein.  While AQP1 is localized 
to the flagella of promastigotes, upon phosphorylation, it is distributed over the entire 
surface of the parasite. Absence of phosphorylation of AQP1 restricted its localization to 
flagellum only (Mandal et al., 2012).  Interestingly, while MPK2 upregulated the 
expression of either AQP1K12Aor AQP1K12R, the altered protein was localized to 
flagellum only.  I interpreted this observation as lysine 12 being critical to pellicular 
localization of AQP1.  The mechanisms for targeting proteins to flagella are now just 
being defined and are crucial to our understanding of flagellar function in kinetoplastids.  
In trypanosomes, a consensus tripeptide motif histidine–leucine–alanine (HLA) contained 
within two cytoskeletal flagellar proteins, paraflagellar rod A and actin-related protein, 
represents an essential part of a flagellar targeting machinery (Ersfeld and Gull 2001).  
However, such a feature is not universal.  For example, the Leishmania enriettii glucose 
transporter, ISO1, resides primarily in the flagellar membrane, whereas the ISO2 glucose 
transporter is located in the pellicular plasma membrane.  Deletion analyses suggest that 
the flagellar targeting information for ISO1 does not constitute a simple linear sequence 
of amino acids but a minimum of two separate sequences in tandem (Nasser and Landfear 
2004). While no such sequence has been identified in Leishmania AQP1, our current 
observation leads us to speculate that, the N-terminus cytosolic region along with 
residues in loop D may be involved in targeting AQP1 between various cellular 
membranes.  In the absence of transcriptional control, such a post-translational regulatory 
mechanism provides a novel way for Leishmania to survive during its digenetic life 
cycle.  It is tempting to speculate that MPK2-mediated upregulation of AQP1 may 
counter the osmotic stress, which is critical for survival and transmission of the parasite 
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between two environments, the vector and the vertebrate host.  On the other hand, the 
intrinsically disordered N-terminal domain containing lysine12 may serve as an on-off 
switch for proteasomal-dependent degradation, especially during drug exposure, thereby 
conferring resistance.  
In addition, I studied the role of 3’-UTR in species-specific stability of AQP1 
mRNA in Leishmania.  As described in previous sections, due to the absence of 
promoters, protein coding genes are constitutively transcribed from large gene clusters as 
polycistronic pre-mRNAs in Leishmania.  Most of the post-transcriptional gene 
regulation mechanism studies performed to date is based on stage specific gene 
expression in Leishmania, which involves 3’UTR elements that mediate the regulation at 
the level of mRNA abundance and translation, respectively.  In this study, I worked with 
six different species of Leishmania: three cutaneous (L. major, L. tropica and L. 
panamensis), one mucocutaneous (L. braziliensis) and two visceral (L.donovani and 
L.infantum).  When promastigotes (all six species) were exposed to increasing 
concentrations of potassium antimonyl tartarate, I observed that visceral species were 
more resistant to Sb(III) as compared to cutaneous species (Table 4) whereas Sb(III) 
accumulation was found to be much higher in Cutaneous leishmaniasis species (Figure 
32).  As Sb(III) accumulation was higher in Cutaneous leishmaniasis species, I measured 
the total non-protein thiol levels, which are markers for antimonial resistance, and found 
them to be similar in all of the species (Figure 33).  When I exposed the promastigote 
cells to hypo-osmotic medium in order to measure osmoregulation, decreased levels of 
AQP1 levels were observed in VL species, and their osmoregulatory capacities were 
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much less compared to Cutaneous leishmaniasis species (Figure 34).  To determine 
whether the species–specific antimonial sensitivity in Leishmania is driven by regulation 
at the mRNA level, I treated the promastigote cells with sinefungin followed by 
actinomycin D.  I observed that AQP1 mRNA was highly unstable in VL species as 
compared to the Cutaneous leishmaniasis species (Figure 35).  In the absence of 
transcriptional control in Leishmania, the role of AQP1 3’-UTRs was determined in the 
species-specific stabilization of AQP1 using the luciferase reporter assay.  3’-UTRs from 
each of the six species were cloned.  It was found that Cutaneous leishmaniasis 3’-UTRs 
of AQP1 mRNA were similarly stable in VL species as they were in Cutaneous 
leishmaniasis species, which implies that there is no effect from any species-specific 
trans-acting factors.  Therefore, this study is highly significant.  We have shown for the 
first time that species-specific antimonial sensitivity in Leishmania is uniquely driven by 
AQP1, and it is mediated by post-transcriptional regulation through the respective 3’-
UTR of each species-specific AQP1 mRNA.   
This study has contributed to our understanding of the regulatory mechanism(s) of 
the drug facilitator AQP1, which has significant roles in the physiology of the parasite 
Leishmania as well as in its clinical resistance to antimonial drugs, the first lines of 
treatment against all forms of leishmaniasis.  Leishmania AQP1 is novel in the AQP field 
because of its unique localization and its role in osmotaxis.  My work established the 
critical role that AQP1 plays in the signal transduction interface of the parasite and its 
environment and that it interacts with other cellular molecules at the post-translational 
and post-transcriptional levels.  These findings address a major gap in our understanding 
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of Leishmania biology at the molecular level.  Overall, Leishmania AQP1 bears about 
30% similarity to mammalian AQP9, which might make it difficult (but not impossible) 
to develop inhibitors targeted to AQP1.  Conversely, unique regulators of AQP1 could be 
reasonable targets.  For example, since protozoan MAP kinases are distantly related to 
human MAP kinases, it may be possible to design compounds that specifically target the 
protozoan enzymes.  One approach may be the development of specific small molecule 
inhibitors of Leishmania MAPK2 activity.  Such compounds may prevent 
phosphorylation of the protozoan AQP1 channel, resulting in increased turnover, possibly 
killing the parasites through osmotic stress.  Another approach may be to identify small 
molecule inducers of MPK2 that might stabilize AQP1 and either reverse drug resistance 
or reduce drug toxicity by reducing the effective dose. 
Drug resistance is a major impediment in treating leishmaniasis.  To date, the 
species-specific antimony resistance had not been explored.  My data supports the 
concept that treating all types of leishmaniasis with the same systemic dosage of 
antimony may not be the best practice.  A lower concentration for the visceral infection 
(which may be the correct dose for the cutaneous species as they are more sensitive) may 
lead to the emergence of a more drug-resistant phenotype in that species.  The results of 
this study may be relevant to the broader field of infectious diseases.  Most physicians 
and scientists treat related species of a specific pathogen in similar ways.  However, I 
propose that there may be differences in interspecies drug resistance within a single 
genus.  Protozoan parasites such as Leishmania that depend on post-transcriptional and/or 
post-translational regulation, rather than transcriptional control, utilize one of these single 
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mechanisms to control species-specific drug resistance.  AQP1 is an adventitious 
antimonite facilitator in Leishmania.  In addition, the osmoregulation in the host and 
osmotaxis in the vector are dependent on AQP1.   Tissue tropism in Leishmania is 
species-specific.  If species-specific regulation of AQP1 is at play in Leishmania, it is 
tempting to speculate that it may be involved in species-specific tissue tropism.  The 
mechanism(s) of tissue tropism is one of the holy grails of Leishmania research.  Thus, 
the results of this study may open up significant research in that direction. 
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